ROLE OF HETERODOX INNATE IMMUNE DEFENSES IN GASTROINTESTINAL HEALTH AND DISEASE by Tubbs, Alan Lewis
 
 
ROLE OF HETERODOX INNATE IMMUNE DEFENSES IN GASTROINTESTINAL 
HEALTH AND DISEASE 
Alan Lewis Tubbs 
A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor in Philosophy in the Department 
of Microbiology and Immunology. 
Chapel Hill 
2018 
 Approved by: 
 Roland Tisch 
 Ryan Balfour Sartor 
 Shehzad Sheikh 
 Maureen Su 























Alan Lewis Tubbs 






Alan Lewis Tubbs: Role of Heterodox Innate Immune Defenses in Gastrointestinal Health and 
Disease 
(Under the direction of Edward A. Miao) 
 
 
The intestinal epithelium constitutes the largest barrier between the host and the outside 
environment of any bodily surface. As such, the intestinal barrier must be prepared to interact 
with a wide range of resident microbes, as well as environmental stimuli, in addition to its 
physiologic role in nutrient digestion and absorption. However, this also means that intestinal 
epithelial cells are the target of an extensive list of pathogens, ranging from eukaryotic parasites, 
intracellular and extracellular bacterial pathogens, and viruses. Thus, the immune system must 
defend this niche against myriad threats without compromising its vital physiologic functions, a 
reflection of the dogmatic immunologic trade-off between potential infection (insufficient 
immune defense) and potential immunopathology (hyper-immune response). To achieve this 
delicate balance, a complex, interactive network of intra- and extra-cellular sensory systems, 
signaling cascades, cytokine responses, and immune cells evolved to integrate a variety of 
unique stimuli into a specific, yet potent, defense system. Nevertheless, as with any convoluted 
system balanced on the razor’s edge of sufficiency, any perturbations to this system can rapidly 
skew the immune system either towards insufficient defense or auto-immunity.  
In this dissertation we examine two components of this byzantine interplay, each of 
which demonstrates the universality of the immunologic tradeoff by providing additional 
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immune defense, while also illustrating the potential risks of such defenses. We begin in Chapter 
1 by summarizing the threats and defenses within the intestinal niche. In Chapter 2, we provide a 
more survey of the immune response to environmental signals, and report our findings on the 
ability of the immune system to respond to sodium ions as a pro-inflammatory signal, with 
particular reference to immunopathology caused by misappropriation of this system. In Chapter 
3, we summarize a burgeoning field of intestinal epithelial cell-intrinsic immune defenses to 
pathogens, and demonstrate a new mechanism of cell death designed to rapidly protect the host 
against infection. In Chapter 4, we conclude with a discussion of these mechanisms and their 
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CHAPTER 1: INTRODUCTION 
 
The gastrointestinal (GI, or gut) tract is one of the more complex organ systems in any 
multicellular organism. The gut is responsible for the digestion of complex foods, absorption of a 
range of nutrients, and maintenance of a diverse microbiota. As such, the intestines must be 
sensitive to a wide array of environmental stimuli and manage an interactome of microbial 
communities, all while extracting the nutrients necessary for the host. The result is a highly 
complicated organ with several unique features.  
For one, the GI tract is an expensive tissue from an energetic standpoint: at 12.2 Watts 
(i.e. joules/s)/ kg of tissue, the gut costs as much as the liver, slightly more than the brain, and 
twice as much as the lungs at rest in humans(1). In fact, according to the “expensive tissue” 
hypothesis(2), the intestines of Homo sapiens were so expensive that in order to compensate for 
outsized brain mass, the human GI tract is significantly reduced compared to a comparably sized 
primate(1), and examples of inverse correlations between brain and GI tract size have been 
observed in birds(3, 4), fish(5, 6) and other primates(1, 7). Although this likely does not 
completely explain the foreshortened intestine in humans relative to primates, it does suggest an 
evolutionary pressure on the immune system to protect this energetic investment. 
Moreover, this expensive tissue is the largest epithelial surface of the entire body, as it 
must be in order to accomplish its myriad functions. However, the extraordinary length 
combined with the uniquely nutrient-rich environment means that the intestine is also one of the 
most highly infected organs of the body. Numerous “professional” pathogens of all kingdoms 
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attack the GI tract, such as bacteria (e.g. Salmonella, Listeria, Shigella, Campylobacter, 
Clostridium difficile, Enteropathogenic and Enterohemorrhagic E. coli, Vibrio), viruses (e.g. 
Poliovirus, Norovirus, Rotavirus, Adenovirus, Astrovirus), fungi (e.g. Aspergillus spp, Candida 
albicans), protists (e.g. Giardia, Blastocysis, Cryptosporidium, Entamoeba), helminths (e.g. 
Ascaris, Cestoda, Taenia), flukes (e.g. Fasciolopsis, Schistosoma), and round worms (e.g. 
Ancyclostoma, Anisakiasis, Enterobius, Trichinella, Trichuris). In addition, the microbiota itself 
may harbor potentially virulent opportunists (e.g. Helicobacter, Proteus, Klebsiella, 
Prevotellacea) that need only the space to expand or an opportunity to attack the intestine(8-10). 
Alternatively, the microbiota may incidentally damage the host while responding to 
inflammation or by processing intestinal contents, as has recently been demonstrated for a 
number of oral chemotherapeutics(11-13) (reviewed (14)).  
Because of the combination of its critical function, its high cost per unit of tissue, and the 
number of organisms that have evolved to attack it, the GI tract has inordinate defense needs. It 
is not surprising, therefore, that the intestines are the largest immune organ in the entire body, 
containing more immune cells than any other tissue (15). However, just like the tissue itself, the 
gastrointestinal immune system has evolved a high degree of complexity in order to achieve its 
task: namely, to differentiate between potentially pathogenic and non-pathogenic organisms in 
the gut, and to protect the tissue without inducing inordinate and pathologic inflammation. To 
achieve this critical balance, the GI tract has combined a number of orthodox immune defenses 
common to many other tissues, as well as some novel defensive mechanisms unique to the task 
at hand.  
In this dissertation, we examine two relatively heterodox innate immune surveillance 
mechanisms that appear to be unique to epithelial surfaces, with potentially significant impacts 
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on gastrointestinal health and disease. We term these defenses heterodox, as they are orthodox 
defenses (e.g. MAP kinases, inflammasomes) that are expressed in novel tissues or used in novel 
ways, in contrast to unorthodox defenses (e.g. NLRP1b) which are unlike all other similar 
defenses and consequently defy paradigms. We begin by summarizing the orthodox state of 
surveillance and defense, before discussing several of the innate immune innovations unique to 
the gut to provide context for our work. 
ORTHODOX INNATE IMMUNE SURVEILLANCE AND DEFENSE  
Like most tissues, the GI tract is constantly surveilled by the innate immune system, 
generally described as a rapid but generalized immune defense capable of detecting potential 
danger and slowing or stopping the infection from spreading. A number of cells and secreted 
proteins work together to achieve this goal, but principle among them are the workhorses of 
innate immunity: macrophages and dendritic cells (DCs), sentinel cells that patrol almost every 
tissue. These first-responders typically find and phagocytose contaminants, either eliminating 
them, or serving as antigen presenting cells (APCs) by taking them to nearby lymphatic tissue to 
present them to begin an adaptive immune response. In contrast, adaptive immunity serves as the 
long-lived, antigen-specific, sterilizing arm of the immune system. Together, these two arms are 
sufficient in humans to detect, counteract, and eventually purge nearly all infectious agents (Fig. 
1.1A).  
 To accomplish these critical surveillance functions, sentinel cells typically express a wide 
array of extracellular and intracellular pattern recognition receptors (PRRs) – germ-line encoded 
receptors such as the Toll-like receptors (TLRs) or the Nod-like receptors (NLRs) that activate 
downstream defenses upon recognition of molecular patterns broadly conserved across 
evolutionary space and time. These molecular patterns are generally split into two categories. 
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Pathogen-associated molecular patterns (PAMPs) - such as bacterial LPS, viral nucleic acids, or 
fungal carbohydrates - are molecules that universally indicate the presence of particular kinds of 
microbes, and are difficult for those organisms to modify to avoid detection. In contrast, danger-
associated molecular patterns (DAMPs) are general signals of stress or alarm that alert the 
immune system to potential damage or infection, and include ATP, cellular DNA, cytosolic 
proteins. Beyond these PRRs, however, exist other, more esoteric sensor systems such as the g-
protein-coupled receptors (GPCRs), and the sensor kinase cascades, each of which tend to 
respond to physiologic and sometimes inflammatory stimuli such as growth factors or 
hyperosmolarity, respectively(16-18). Examples of the latter group include the mitogen-activated 
protein kinases (MAPKs), the illuminatingly-named extracellular signal-regulated kinases 
(ERKs), and the c-jun N-terminal kinases (JNKs). 
 As with any tissue, the role of these sensors – and the PRRs in particular - is twofold: 1) 
detect potential dangers; and 2) initiate threat-appropriate responses. To do this, PRRs typically 
surveil specific locations, and upon activation, signal to downstream transcription factors, 
proteases, and kinases. These, in turn, amplify the original signal by secreting cytokines, 
recruiting new cells through chemokines, and clearing the infection via phagocytosis and 
cytotoxicity. These responses can also lead to the generation of adaptive immune responses by 
providing a cytokine milieu that informs lymphocytes of what kind of T and B cells response is 
required, as well as by sending APCs to the relevant draining lymph node to present antigen. 
 For example, sentinel cell TLRs surveil the extracellular space of the tissues they inhabit 
tissues and their own vacuolar spaces. TLRs typically detect PAMPs that could come from any 
bacteria or virus, without discriminating between pathogenic and non-pathogenic organisms. 
That is, RNA from either pathogenic viruses or harmless phage can activate TLR3, while LPS 
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from commensal bacteria and pathogens alike activates TLR4. Upon activation, TLRs signal 
through intermediaries like MyD88, or TRIF, generating broadly anti-bacterial responses (e.g. 
TNF, IL-6, IL-12 etc) or antiviral responses (e.g. interferons), respectively. Because these 
cytokines typically alert other cells and begin the process of generating a T cell response without 
hyperinflamming tissue, TLR activation is typically thought of as a “yellow-alert” signal that 
amplifies PAMPs(19). Thus, TLRs discriminate between the presence or absence of microbes.  
In contrast, intracellular sensors like the NLRs discriminate between virulent and non-
virulent bacteria by directly detecting determinants of virulence – such as the rod and needle 
components of bacterial Type 3 Secretion Systems via NAIPs – or consequences of virulence – 
such as manipulation of cellular Rho GTPases by Pyrin(20), LPS shed in the cytosol by infecting 
bacteria via caspase-11(21, 22) or cellular catastrophe via NLRP3.  Upon detection of their 
respective ligands, NLRs typically bind to and activate caspase-1, an inflammatory cell death 
protease; sensors that do this are termed inflammasomes. Caspase-1 both: 1) initiates recruitment 
of neutrophils and cytotoxic lymphocytes through the cleavage and secretion of the highly pro-
inflammatory cytokines pro-IL-1β and pro-IL-18, respectively; and 2) initiates highly 
inflammatory cell-death termed pyroptosis(23). This is achieved by cleaving gasdermin D 
(encoded by Gsdmd)(24, 25), which oligomerizes into pores in the outer membrane of a cell, 
resulting in rapid osmotic lysis, release of these cytokines, and entrapment of the infectious agent 
in the residual cellular corpse (pore-induced trap, or PIT)(26). The result of this “red alert” signal 
is the removal of a niche for an infecting organism(27), immobilization of that organism, and a 
highly targeted recruitment of microbicidal neutrophils (via IL-1β), cytotoxic natural killer (NK) 
cells and CTLs (via IL-18) to the location of the infection.  
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Together, these defenses are sufficient for defense of most tissues. However, the GI tract 
has a number of unique modifications of these surveillance systems for its own purposes. 
HETERODOX INNATE IMMUNE SURVEILLANCE AND DEFENSE IN THE GUT 
As noted above, the gastrointestinal tract is a vast epithelial organ that harbors an 
extensive and complicated microbial community and encounters unique environmental stimuli. 
While both are important to the health of the host, they also carry with them a number of 
dangers, including the risk of a potentially infectious organism colonizing the gut or a dangerous 
contaminant damaging the epithelium. In order to counter these dangers while preserving normal 
tissue and microbiota function, the gut has evolved a number of unique immune surveillance and 
defense features. We outline three: 1) a tradeoff between yellow and red alert signals; 2) pre-
arming of the epithelium; 3) and a sensitivity to metabolites and environmental stimuli. 
Trust but Verify: Hyporesponsiveness and Hypervigilance   
Unlike an internal organ, the GI tract is constantly exposed to a number of PAMPs and DAMPs, 
effectively raising the noise-to-signal ratio of many PRRs and making them useless as 
determinants of danger or infection. Despite the presence of a mucosal layer and tight junctions 
between intestinal epithelial cells (IECs), the presence of LPS or nucleic acids in the lamina 
propria underlying the epithelium is not necessarily an informative signal of danger. For 
example, M cells, a specialized cell in intestinal lymphoid tissue, constantly traffic contents of 
the intestine into tertiary lymphoid tissues such as Peyer’s patches in the small intestine for 
collection and presentation by APCs(28). It has also been suggested that some microbial 
products can transit across the epithelium freely, leading to a so-called “leaky gut”(29).  
Together, such mechanisms would render most TLR signaling useless (Fig. 1.1B).  
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In line with this assumption is the observation that sentinel cells of the GI tract appear to 
have evolved hyporesponsiveness to such stimuli. It has been noted that many lamina propria 
macrophages (LPMφ) may not express TLRs(30), or that ligation of the few they do express may 
upregulate IL-10 secretion rather than pro-inflammatory cytokines, chemokines, or co-
stimulatory molecules(31) (the exception being TLR5(30)). This engagement of ligands and 
receptor endocytosis without response would thus remove stimuli from circulation without 
generating commensurate, inappropriate inflammation (32). Similarly, LPMφ do not chemotax to 
microbial stimuli as well as macrophages in normally sterile organs(33, 34). Oddly enough, 
intestinal monocytes are non-self-replenishing, instead deriving from CX3CR1
hi blood 
monocytes(35-37), which differentiate in the intestine(38, 39) and must downregulate 
inflammatory gene circuits to prevent colitis. Indeed monocytes that cannot adapt, such as those 
lacking the IL-10R, drive a spontaneous and uncontrollable colitis(40, 41). The result of such 
modifications is that the GI tract seems unwilling to respond to general microbial determinants – 
perhaps appropriate to an organ designed to tolerate enormous adjacent microbial communities.  
One might suspect that the loss of surveillance for the presence of microbes would make 
the intestine more susceptible to infections, since the immune system can no longer utilize a 
yellow-alert signal to respond to initial contamination. However, gut innate immunity appears to 
have compensated by increasing surveillance for the presence of virulence instead. Lamina 
propria macrophages and DCs retain their intracellular sensor complement(42), and also 
constitutively express ASC, NLRP3, and the cytokines proIL-1β and proIL-18 (extracted from 
(39, 43)), but have more opportunities to surveil the lumen and thus sample for virulence 
determinants. As noted above, M cells shuttle luminal contents to APCs like macrophages and 
DCs, and any barrier leakiness or breaches would merely provide more content for these cells to 
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sample. Indeed, APCs even directly sample the intestinal lumen, exposing themselves to 
potential infection repeatedly. This sampling is so pervasive that non-motile strains of 
Salmonella Typhimurium can systemically infect mice after oral administration, likely via 
engulfment by innate immune cells of the intestinal epithelium(44). M cells, particularly in the 
colon, also increase during inflammation, leading to increased sampling once pathologic 
determinants have already been detected(45) (Fig. 1.1C). 
Interestingly, the epithelium also harbors a unique immune cell population termed intra-
epithelial lymphocytes (IELs). These cells exist at a staggering ratio of 1 IEL to every 10 
epithelial cells(46, 47), and constantly interdigitate between them as they move about the 
epithelial surface(48). While little is known about these cells, they have been shown to have 
potent cytotoxic abilities, leading to the suspicion that these cells actively survey the epithelium 
for potentially infected cells, which they then kill via perforin/granzyme B, Fas-Fas ligand 
interactions, or other methods(46).  
All of these enhanced vigilance mechanisms are supplemented by extensive gut-
associated lymphoid tissue (GALT), including Peyer’s patches (which harbor M cells), and 
lymphoid aggregates. This enables antigens brought from the lumen to rapidly be trafficked to 
lymphocytes for the initiation of adaptive immune responses if necessary. While this might 
otherwise result in spurious inflammatory responses to resident microbes, the intestinal 
epithelium is replete with regulatory T cells (Tregs) that respond to specific antigens by 
producing the immune-suppressive IL-10 and TGFβ cytokines, thus preventing such accidental 
immunopathologies(49, 50). Nevertheless, sufficiently strong cytokine activation and 
inflammation, such as that associated with inflammasome activation, pyroptosis, and IL-1β/IL-
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18 secretion can override this suppression, enabling pathogenic-specific adaptive immune 
responses (51). 
Armed Citizenry: Rapid Intestinal Immune Responses from the Stroma  
While enhanced sampling and additional surveilling cells can help to compensate for the 
loss of yellow alert signals in the intestine, they cannot compensate for the loss of gene 
expression initiated by these signals. As mentioned above, this explains the constitutive 
expression of numerous red-alert cytokines and inflammasomes in lamina propria macrophages 
and DCs. It appears, however, that this strategy has also been appropriated for use in epithelial 
cells. IECs express several intracellular sensors, including NLRC4, NAIP2, and NAIP5, as well 
as NLRP6 and ASC, but not NLRP3, as has been previously noted(52). Downstream, they 
express caspases-1 and -11, as well as caspases-7 and potentially -6. They also express the 
pyroptosis-inducing gasdermin D, as well as several members of the gasdermin C family, whose 
in vivo function have not yet been described (Fig 1.1B, insert). They too do not require a yellow-
alert signal to express inflammasome-dependent cytokines, but unlike their monocyte sentinels, 
however, they only constitutively express IL-18, but not IL-1β(30, 52, 53). Thus, IECs appear to 
be perfectly poised to respond quickly and strongly to cytosolic PAMPs, and particularly those 
of bacteria.  
Indeed, recent studies have already shown that arming IECs has effects in vivo.  Infection 
by SPI-1-expressing Salmonella enterica serovar Typhimurium leads to expulsion of infected 
cells from the epithelium, while SPI-2-expressing bacteria are retained(54). In addition, other 
groups have shown that IEC NAIP/NLRC4 axis activation directly leads to this exfoliation, as 
well as to pyroptosis by gasdermin D (55, 56). In fact, exfoliation seemed to be dependent on 
inflammasome-apoptosis cross-talk, as NLRC4 activation lead to caspase-8-dependet exfoliation 
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of cells, even without pyroptotic pore formation(56). Similarly, infection and exfoliation of IECs 
by S. Typhimurium leads to release of IL-18, resulting in exacerbated pathology due to NK cell 
recruitment and cytotoxicity(55). These rapid pyroptosis and exfoliative mechanisms have been 
proposed as rapid ways to remove infected cells from the host without having to wait for the 
input of cytotoxic lymphocytes, as would presumably be required in other, non-barrier tissues. 
Thus, arming epithelial cells with inflammasomes appears to be a critical way to circumvent the 
loss of effective extracellular sensing and inter-cellular communication, allowing infected cells 
to rapidly decide their own fate and raise the alarm in cases of infection. 
Expanded Surveillance Programs: Unique Sensors in the intestinal immune system  
Beyond the traditional sensor cells and systems, the intestinal immune system also 
employs a number of specialized immune cells to help surveil and maintain the tissue. In 
addition, the intestine seems to have an expanded sensor palate capable of responding to the 
numerous unique stimuli found in the intestine. While characterization of these cells and sensor 
mechanisms is ongoing, a few examples taken from both innate and adaptive immunity are 
sufficient to illustrate the concept.  
Expanded immune cell subsets. In addition to the specialized lamina propria macrophage 
and dendritic cell populations outlined above, the intestine harbors large numbers of specialized 
immune cells such as innate lymphoid cells (ILCs) and intraepithelial lymphocytes (IELs). 
ILCs are innate-acting lymphocytes discovered first as lymphoid-tissue inducer cells in 
the intestine in the waning years of the 20th century(57, 58). However, it took another decade to 
fully identify the importance and distribution of these cells throughout the body. Dependent on 
lineage specific transcription factors and the factor ID2(59), these cells are capable of innate 
activation and secretion of cytokines produced by antigen-specific T cells without antigen 
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specificity. NK cells are perhaps the best example, mirroring CD8 cytotoxic lymphocytes, but 
the appropriately named ILC1s, ILC2s, and ILC3s can also rapidly initiate the immunologic 
programming of their adaptive relatives (Th1, Th2, Th17, respectively)(60-62). Critically, these 
cells play important roles in the gut, either in defense or homeostasis. ILCs of all three lineages 
are enriched in the intestine, and appear to be more sensitive to alarmins, cytokines, and growth 
factors, enabling rapid responses to danger. In turn, these cells are critical for the defense against 
a number of pathogens(61, 62).  However, reports also indicate that some cells, such as the 
MHC-II+ ILC3s maintain homeostasis by presenting resident antigens in the absence of co-
stimulatory molecules, thus tolerizing cognate antigen-specific T cells(63). Within the paradigm 
of heterodox defenses of the intestine, ILCs seem an ideal defensive auxiliary, bespoke to a 
tissue that might need fast-twitch lymphocyte cytokine and cytotoxic functionality without 
suffering the delay of developing in the lymph node. Indeed, deficiencies in these cells in the 
intestine leads to defects in infection and tolerance(64).  
IELs are a longer known but more cryptic lymphocyte population first discovered in the 
epithelial tissues of the lung and intestine(65, 66). Indeed, describing IELs as a single population 
is misleading, as IELs vary significantly both between humans and mice, as well as between 
individual animals, potentially reflecting their species and individual histories(67). In the mouse, 
for example, while almost all IELs in the gut are T cells, they tend to be quite distinct from 
typical T cells, expressing TCRγδ or CD8αα molecules in significant proportions as well as the 
E-cadherin-interacting αE integrin. These cells also express activation markers and can rapidly 
secrete effector cytokines including IFNγ, IL-2, IL-4, and IL-17. In addition, IELs are capable of 
cytotoxic activity against epithelial cells, as they express perforin, granzymes A, B, and K, and 
Fas, thus merging potent cytokine secretion and cytotoxic surveillance to maintain health of the 
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epithelium (Fig. 1.1C, insert). Interestingly, murine IELs also express a number of innate natural 
killer receptors and the non-classical MHC proteins CD1d, and respond to the IEC-expressed 
thymus leukaemia antigen via CD8αα(46, 68). These data suggest that IELs are actively 
surveilling IECs and the lamina propria for markers of distress or damage, thus enabling rapid 
and diverse sensing of the intestinal barrier.  
Expanded Sensor Repertoire. The intestine also seems capable of or prepared to respond 
to multiple unique stimuli not likely found in other tissues. For example, reports indicate the 
intestine can sense and respond to lipids(69, 70), sugars, proteins, fibers, and mineral ions(69-
71). Often detection of these compounds is mediated through specialized stromal and endocrine 
cells and disseminated by hormonal signaling. For example, dietary carbohydrates appear to be 
sensed specifically by the taste receptor gustducin, leading to upregulation of sodium-coupled 
glucose transporters (SGLT1). Indeed, numerous cells, particularly tuft cells, express a wide 
variety of taste receptors that may detect dietary compounds and regulate nutrient absorption 
accordingly(71).  
However, the intestinal immune system also seems primed to detect certain 
environmental and dietary compounds that pass through the intestine. For example, the aryl 
hydrocarbon receptor (Ahr), first discovered in the intestine, is highly expressed on Th17 cells in 
the intestine and is important for their regulation and homeostasis(67). Ahr responds to a number 
of ligands, including tryptophan derivatives, and has been demonstrated to have both pro- and 
anti-inflammatory effects in the intestine, suggesting a complex interplay between sensing and 
responses(72, 73). More recently, reports have shown that the intestinal immune system responds 
to short-chain fatty acids (SCFAs) derived from breakdown of dietary fiber by subsets of gut 
bacteria, and that the loss of these SCFAs or their receptor, Ffar2, leads to reduced Treg numbers 
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and functionality in the gut(74). Intriguingly, Tregs themselves do not express Ffar2 (expression 
data from (75)); rather, lamina propria DCs appear to strongly express the receptor, suggesting 
that the lamina propria sentinel cells are also involved in detection of dietary or environmental 
factors and modulating the immune system accordingly(39).  
CONCLUSION 
The work described in Chapters 2 and 3 build on the concept of heterodox immune 
defenses in intestinal homeostasis and defense. Chapter 2 specifically elaborates on the idea that 
the intestinal sentinel compartment is capable of responding directly to dietary factors like Na+ 
by enhancing proinflammatory cytokine production and inflammation. Chapter 3 elaborates on 
the concept of the innate-armed stroma, incorporating the enigmatic caspase-7 into a pathway of 
IEC defense and extrusion against intestinal pathogens. We then discuss these findings in the 










Figure 1.1 Orthodox and Heterodox Innate Immune Defenses in Inflammation and 
Homeostasis. A non-exhaustive summary of the relevant defenses discussed in this dissertation. 
(A) Macrophages (Mφ) and dendritic cells (DC) detect threats through external TLRs that drive 
interferon, cytokine, and chemokine expression. Meanwhile, intracellular sensors such as 
inflammasomes defend against infection by initiating red-alert cytokine production and 
pyroptosis to prevent intracellular replication. DCs also collect relevant antigens and bring them 
to the draining lymph node, which, in combination with cytokine and chemokines, help recruit 
additional leukocytes and lymphocytes. (B) During intestinal homeostasis, M cells in Peyer’s 
patches help underlying Mφs and DCs sample the luminal content, which contains a number of 
unique stimulants, such as short chain fatty acids (SCFAs). Because of the superfluity of TLR 
agonists in the environment, however, underlying leukocytes do not typically express TLRs. 
Instead, epithelial cells themselves express inflammasomes in order to protect against infection 
directly. In addition, innate-acting ILCs and IELs help patrol the periphery to maintain health. 
(C) However, during inflammation, the intestine rapidly shifts to a pro-inflammatory stance. In 
addition to the ordinary mechanisms suggested in (A), several other defenses come into play. For 
example, organisms that attack or invade IECs can trigger inflammasomes, leading to pyroptosis 
and secretion of cleaved IL-18. Inflammation can lead to the production of cytokines and 
chemokines, either from resident cells or ILCs, which in turn suppress Tregs and recruite new 
cells. This includes blood monocytes, which are quickly recruited to the tissue and retain TLR 
expression, thus amplifying inflammatory signalling. In addition, cytotoxic IELs presumably 
help remove damaged or infected cells from the epithelial barrier to slow infection, while 
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CHAPTER 2: DIETARY SALT EXACERBATES EXPERIMENTAL COLITIS2 
 
SUMMARY 
The Western Diet – characterized by high protein, sugar, fat and low fiber intake – is 
widely believed to contribute to the incidence and pathogenesis of inflammatory bowel diseases 
(IBD). However, high sodium chloride salt content, a defining feature of processed foods, has 
not been considered as a possible environmental factor that might drive IBD. We set out to 
bridge this gap. We examined murine models of colitis on either a high salt diet (HSD) or a low 
salt diet (LSD). We demonstrate that a HSD exacerbates inflammatory pathology in the IL-10-
deficient murine model of colitis relative to mice fed a LSD. This was correlated with enhanced 
expression of numerous pro-inflammatory cytokines. Surprisingly, sodium accumulated in the 
colons of mice on a HSD, suggesting a direct effect of salt within the colon. Similar to the IL-10-
deficient model, a HSD also enhanced cytokine expression during infection by Salmonella 
typhimurium. This occurred in the first three days of infection, suggesting that a HSD potentiates 
innate immune response. Indeed, in cultured dendritic cells we found that high salt media 
                                                          
2  This chapter contains a manuscript that previously appeared as an article in The Journal of 
Immunology. I collected and analyzed the data in all figures, and co-wrote the manuscript with 
Dr. Miao. This is the author's version of the work. The definitive version was published in J 
Immunol 199, 2017, doi: 10.4049/jimmunol.1700356. The full citation is: Tubbs A.L., Liu B., 
Rogers T.D., Sartor R.B., Miao, E.A. “Dietary Salt Exacerbates Experimental Colitis.” The 




potentiates cytokine expression downstream of TLR4 activation via p38 MAPK and SGK1. A 
third common colitis model, administration of dextran sodium sulfate (DSS), was hopelessly 
confounded by the high sodium content of the DSS. Our results raise the possibility that high 
dietary salt is an environmental factor that drives increased inflammation in IBD.  
INTRODUCTION 
The Western diet, characterized by foods high in salt, sugar, protein, and fat, but low in 
fiber from fruits and vegetables, has long been understood to drive atherosclerosis, diabetes, 
inflammatory bowel disease (IBD), and other diseases of the developed world (1, 2). For 
example, the incidence of Crohn’s disease – one of the two primary IBDs – is 4 times higher in 
North America than in the Middle East or Asia, reflecting the fact that environmental stimuli like 
diet drove enormous surges in incidence in developed countries in the last fifty years (3-5). 
Further, numerous recent studies have linked elements of the Western diet to poor 
gastrointestinal health: diets high in sugar and fat lead to a dysbiotic, pro-inflammatory 
microbiota (6), while diets low in fiber lead to poor immunosuppressive activity of Tregs and 
dysfunctional immunity (7).  
One aspect of the Western diet that has not been studied in the context of IBD, however, 
is dietary salt (NaCl). Processed foods typical of a Western diet can contain 100 times the NaCl 
of similar home-cooked meals (8, 9), and many Americans consume more than twice the 
American Heart Association’s daily recommended NaCl content. High NaCl consumption is 
associated with increased risk of developing high blood pressure (10), correlates with increased 
disability and progression in multiple sclerosis (11), interferes with and damages normal kidney 
function (10, 12-14) and may be involved in atherosclerosis (15). These data are corroborated by 
studies in human volunteers, where a controlled high salt diet correlated with enhanced blood 
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monocyte counts and pro-inflammatory serum cytokines (including IL-17, IL-6, and IL-23) (14, 
16, 17). 
Several recent studies have shown that a high salt diet (HSD) in laboratory mice is pro-
inflammatory (18). Excess NaCl in vitro was shown to enhance Th17 differentiation and activity 
via a p38 MAPK→NFAT5→SGK1 pathway, and that a HSD plus 1% NaCl-supplemented water 
exacerbates experimental autoimmune encephalitis (EAE) in mice (19, 20). Moreover, 
macrophages cultured in hyperosmotic NaCl produced more IL-1β, and WT but not 
inflammasome deficient mice developed worse EAE on a HSD plus 1% NaCl-supplemented 
water (21). In contrast, Tregs cultured in high salt media (HSM) adopted a proinflammatory 
phenotype (expressing Ifng, Il17a, and Rorc) and were unable to suppress inflammation when 
transferred into two different disease models exogenously (22). Similarly, M2 macrophages in 
HSM failed to suppress T cell proliferation, and a HSD plus 1% NaCl water inhibited wound 
healing in vivo (23). Finally, a HSD with 0.9% NaCl water led to hypernatremia in the skin, 
which drove anti-microbicidal activity against Leishmania major by macrophages (24). 
Therefore, a high salt diet has significant pro-inflammatory effects in the brain and skin.  
Since dietary salt is first encountered in the gastrointestinal tract, we hypothesized that a 
HSD would also potentiate intestinal inflammation caused by either immunologic dysfunction or 
bacterial infection.  
RESULTS 
Comparison of mouse HSD chow to human foods.  
The most obvious way a HSD could affect IBD is by elevating NaCl content in the gut, 
which could directly alter the immune system. Although sodium is quickly and efficiently 
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absorbed in the stomach and upper small intestine, a HSD could increase gastrointestinal tract 
salinity locally, or portal blood and lymph to drive systemic effects (19, 20).  
To begin, we considered whether the mouse chow HSD is similar in NaCl content to 
commonly available foods in grocery stores, as well as fast food restaurants. We calculated the 
content by dry weight for these foods using the SELF Nutrition database (25), which uses the 
Nutritional Facts label in the United States. In contrast, mouse chow containing 4.0% w/w NaCl 
is a common HSD, while 0.49% NaCl is a common low salt diet (LSD). Comparing these diets 
revealed that the mouse HSD has comparable salt content to many fast food items (Fig. 2.1A and 
Table S1). Conversely, the LSD was similar to fruits and vegetables. In many murine 
experimental models using a HSD, the water available to the mice also contains 0.9-1.0% w/v 
NaCl (19, 20, 22-24, 28, 29). However, the NaCl content of commonly consumed beverages was 
negligible (Fig. 2.1B and Table 2.1). Therefore, in the studies below, we provided mice with ad 
libitum tap water with no added NaCl.  
 
A HSD causes colonic contents to have high Na+ concentration 
Having established that the mouse HSD is comparable to elements of a Western diet, we 
sought to determine if the HSD alters sodium concentration in the gut. To assess this, animals 
were fed a HSD or a LSD for four days, and sodium content was determined in gastrointestinal 
tissues and contents using a flame photometer. Mice ate equivalent amounts of food and gained 
equal weight on both diets. We expected that sodium would be largely absorbed in the upper GI 
tract, then excreted by the kidney into the urine. Indeed, mice on a HSD drank significantly more 
water and excreted significantly higher concentrations of sodium in their urine starting 12h after 
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administration of the diet, with output stabilizing after two days (Fig. 2.1C). Concomitantly, we 
observed lower potassium concentrations in the urine (Fig. 2.1D). 
Surprisingly, mice on a HSD also contained significantly higher concentrations of sodium 
in their feces (Fig. 2.1E), again with concomitantly lower potassium (Fig. 2.1F). However, the 
idea that high sodium would be present through the GI tract is at odds with the conventional 
wisdom that sodium should be largely absorbed in the upper GI tract (30). 
We therefore measured the sodium concentration of the GI tissue and luminal contents 
for both sodium and potassium. Tissue content was largely similar between the diets throughout 
the GI tract (Fig. 2.1G). As expected, the stomach contents – largely composed of the HSD – 
contained significantly more sodium. This sodium was normalized within the small intestine, but 
was then paradoxically elevated in the colonic contents (Fig 2.1G). As before, GI content 
potassium levels were inverted (Fig. 2.1H). Therefore, the colon contents of mice on a HSD 
experience a local high sodium concentration compared to those on a LSD.  
How can we explain the apparent re-appearance of sodium in the colon? The primary 
function of the colon is to absorb water from the feces by absorbing ions, including sodium. 
However, mice on a HSD are sodium overloaded. This represses aldosterone production, which 
in turn represses expression of the sodium absorption channel ENaC. Thus, on a HSD, the colon 
will absorb potassium rather than sodium (31). Indeed, sodium mass in the cecal and colonic 
content only dropped in LSD animals, while potassium mass dropped in both groups (Fig. 2.1I). 
Then, as water is removed, the concentration of sodium rises (Fig. 2.1I, G). This gives the 
illusion of sodium “re-appearing” in the feces. Interestingly, while potassium is reduced in the 
HSD feces, the magnitude was not equivalent to the sodium elevation. However, since the 
normal osmolar gradient that exists from the villus tip to the villus base exceeds the osmoles of 
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both sodium and potassium in the content, it is likely other osmolytes contribute to water 
absorption (32). 
 
Effect of HSD on experimental murine colitis.  
We sought to determine if the local sodium increase we observed in colon contents might 
alter colonic immune responses. To test this, we examined the effect of our diets in the Il10–/– 
model of murine colitis.  
Il10–/– mice spontaneously develop inflammatory colitis driven by resident intestinal 
bacteria (33). While colitis develops asynchronously under normal SPF housing conditions, 
colonizing adult germ free Il10–/– mice with SPF fecal microbiota synchronizes disease. Mice 
develop progressive colitis beginning after one week, plateauing after 4-6 weeks in our facility 
and lasting for the life of the animal (34, 35). The inflammatory response is characterized by 
transmural mononuclear cell infiltrate in the cecum and colon, as well as epithelial hyperplasia. 
We therefore colonized germ-free Il10–/– and wild type mice on a 129SvEv background and 
simultaneously transferred mice to either a HSD or the LSD. After three weeks we examined 
intestinal inflammation by H&E staining and tissue cytokine expression (Fig. 2.2-3).  
Histologic examination showed that a HSD broadly exacerbates colitis in both the ceca 
(Fig. 2.2A-D) and colons (Fig. 2.2E-J). Both the HSD ceca and colons had increased immune 
infiltration, increased epithelial hyperplasia, and extensive goblet cell loss. In the ceca this was 
accompanied by edema and immune cell infiltration of the submucosa and lamina propria, which 
was not observed in LSD mice (Fig. 2.2C). Qualitatively, the HSD exacerbated blinded 
histologic inflammatory scores in all segments of the colon. The HSD significantly increased 
colitis scores in the cecum, trended towards an increase in the proximal colon, which again 
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became significant in the transverse and distal colonic segments (Fig. 2.2L-N). Germ free WT 
animals colonized with the same SPF displayed no appreciable inflammation in either diet group 
(Fig. 2.2L-M), indicating that a HSD alone is not overtly inflammatory. Consistent with this 
scoring, Il10–/– mice had higher fecal myeloperoxidase (MPO) and lipocalin-2 (LCN2) levels 
(Fig. 2.2N), two luminal biomarkers of inflammation (36). Together, these data suggest a general 
enhancement of inflammation, rather than a specific effect on epithelial growth or immune cell 
infiltrate. 
Previous reports have noted that a HSD is capable of driving enhanced cytokine 
production as well as immune cell recruitment and stronger antimicrobial barrier defenses. 
Therefore, in order to better understand how a HSD exacerbated inflammation in this model, we 
examined transcription of several key cytokines via real-time quantitative PCR (qPCR) within 
the colonic tissues of LSD and HSD- fed mice. Indeed, a HSD induced significantly enhanced 
expression of Tnf and Il12b (Fig. 2.3A-B), as well as the Th17-axis cytokines Il23a, and Il1b, 
though Il6 trended but did not reach significance (Fig. 2.3B-E). Although we observed that a 
HSD increased Il17a expression in our first replicate, the statistical significance of this difference 
was not observed after experiments were combined (Fig. 2.3F). Likewise, the Th1-axis cytokines 
Il12a and Ifng trended but did not reach significant enhanced expression (Fig. 2.3G-H).  
The strong increase in expression of the IL-12 family genes Il23a and Il12b, as well as 
the myeloid cytokine Il1b suggested that macrophages and dendritic cells (DCs) might respond 
to high intestinal sodium. Indeed, macrophages have already been shown to respond to high 
NaCl media (HSM) in vitro, suggesting that myeloid cells are a key sodium-responsive 
population (24). In line with our observations in vivo, we found that LPS-stimulated DCs 
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exposed to HSM produced significantly more proIL-1b, IL-12p40, IL-23p19, and to a lesser 
extent IL-6 (Fig. 2.3I-L) than cells in normal NaCl media (NSM).  
In vitro work has described a p38→NFAT5→SGK1 pathway for enhanced cytokine 
secretion in response to stimulation and HSM (19-21, 24). We tested whether this pathway was 
responsible for the enhanced DC cytokine production using the SGK1 inhibitor GSK 650394 and 
the p38 inhibitor SB203580. As hypothesized, HSM potentiation of IL-23p19 production was 
eliminated by either inhibitor (Fig. 2.3M-N), suggesting that DCs may use the same pathway to 
detect and enhance inflammatory responses in the presence of increased NaCl concentrations.  
These data add DCs to the list of salt responsive cell types, which also includes T cells 
and macrophages (19, 20, 24). Any combination of these cell types could be driving the high salt 
response in our models.  
 
The DSS colitis model is confounded by a HSD and by DSS itself 
The observed increase in expression of Il23a and Il1b suggests an effect on innate 
immune responses. Therefore, we examined the effect of a HSD in the dextran sodium sulfate 
(DSS) model of colitis. In this model, animals are fed DSS, which injures intestinal epithelial 
cells. This drives an inflammatory response to luminal bacteria, the early phase of which is 
primarily mediated by the innate immune system. Thus, by treating HSD or LSD mice with 3% 
DSS for five days, we sought to examine whether a HSD would exacerbate innate immune-
driven intestinal inflammation.  
Although HSD animals did exhibit greater weight loss (Fig. 2.4A), and elevated fecal 
hemoccult scores (Fig. 2.4B), these data are confounded by the fact that mice on a HSD drank 
nearly twice as much DSS water as LSD animals. HSD mice thus received significantly more 
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DSS mass than LSD animals (Fig. 2.4C). We then attempted to normalize DSS consumption by 
reducing the concentration of DSS provided to HSD animals to 1.9% DSS (Fig. 2.4D-F). This 
nearly normalized DSS consumption rates (Fig. 2.4F), but also normalized hemoccult scores 
between HSD and LSD mice.  
This led us to consider whether DSS itself might be ‘salty.’ Indeed, we found that 
depending on the manufacturer, a 3-4% solution provides as many millimoles of sodium per ml 
as a 1% NaCl solution (Fig. 2.4g). Therefore, the HSD and LSD mice both experience high 
sodium intake, but originating from the DSS water, which prevents the study of dietary sodium 
effects in this model. We therefore sought an alternative model to test intestinal innate 
transcriptional responses to a HSD.  
 
A HSD enhances inflammatory cytokines during intestinal infection 
Another model of innate intestinal immune responses is oral infection with Salmonella 
enterica serovar Typhimurium (Fig. 2.5A). Because this model rapidly induces extreme 
inflammation, we speculated that a HSD might generally enhance cytokine responses, but fail to 
further accelerate histologic inflammation. Indeed, S. typhimurium infected mice had similar 
bacterial burdens and histopathology on both diets (Fig. 2.6, 2.5B). Thus, this model allows us to 
examine the effect of a HSD on cytokine expression in isolation from these factors. 
In agreement with the Il10–/– model, HSD mice infected with S. typhimurium also had 
elevated cytokine responses. HSD mice had significantly increased expression of Tnf and Il12b 
(Fig. 2.5C-D), as well as the Th17 axis cytokines Il23a, and Il1b, the latter of which trended 
towards significance, though only reaching significance on day 3 (Fig. 2.5E-F). Likewise, Il6 
trended towards significance, but in this case was statistically significant on days 3 and 4 (Fig. 
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2.5G). Unlike the Il10–/– model, Il17a was significantly increased during S. typhimurium 
infection (Fig. 2.5H). The S. typhimurium model may thus have a greater sensitivity to detect 
cytokine increases, and similarly, the Th1 axis cytokines Il12a and Ifng, which trended in the 
Il10–/– model, were significantly increased by the HSD during S. typhimurium infection (Fig. 
2.5i-j). These results are consistent with the conclusions from the Il10–/– model that a HSD 
enhances innate cytokine responses.  
Because the NLRP3 inflammasome responds to loss of cellular potassium (37), we 
hypothesized that caspase-1/11 knockout mice would fail to respond to a HSD in the S. 
typhimurium infection model. However, despite delayed inflammation from loss of these genes, 
there were still differences in colonic cytokine expression (Fig. 2.7). Interestingly, HSD and LSD 
mice expressed equivalent levels of Ifng and Il17a, which is likely due to the loss of IL-18 and 
IL-1β processing, respectively.  
DISCUSSION 
It is clear that components of the Western diet have significant, negative impacts on 
human health. Evidence suggests the Western diet is linked to the incidence of several 
autoimmune diseases, including multiple sclerosis and diabetes (38). Animal studies have shown 
that diets high in protein, fat, and sugar, and low in fiber can alter immune cell function (7), and 
promote metabolic syndrome (39). Further, the Western diet is associated with an increasing 
incidence of IBD (1, 2). However, the high salt content of the Western diet has not been studied 
as a component that drives IBD.  
Although the effect of dietary NaCl on immune function has been described outside the 
GI track, the mechanism by which dietary NaCl exerts systemic effects is difficult to explain. 
Dogma suggests that sodium is quickly stripped from food in the proximal intestine(30), and is 
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then stored in the skin (24, 29) or re-concentrated in the kidney prior to excretion. Therefore, one 
would expect HSD effects to be limited to the upper GI tract, the urinary tract, and the skin.  
Our data surprisingly argue that a HSD actually creates a high local concentration of 
sodium in the colon. Even though sodium levels from food are rapidly normalized in the small 
intestine, presumably by a combination of ion absorption and intestinal and pancreatic secretion, 
we observed an apparent re-enrichment of sodium in the feces. Nevertheless, this observation 
can be explained by comparison with the reciprocal absorption of potassium.  
Like sodium, potassium levels are normalized in the small intestine. As the contents pass 
through the cecum and colon, both groups of mice absorb potassium, decreasing its mass. 
However, while LSD mice also absorb sodium, HSD mice do not, leaving it behind. This leads to 
an increase in concentration of sodium in the colons of HSD mice relative to the LSD mice as 
water is removed. Therefore, we speculate that humans consuming a Western diet may also 
experience high sodium concentrations in their colons.  
How does luminal salt concentration cause an immunologic response in the seeming 
absence of unchanged tissue salt concentrations? We can imagine numerous possible 
mechanisms. For example, the high sodium concentration in the colonic lumen caused by the 
HSD likely creates a sodium microgradient across the epithelium that is experienced primarily 
by the epithelial cells. These epithelial cells could experience this as a static, elevated 
concentration gradient, or as increased sodium flux across their cytosol and membranes. Both the 
concentration and flux changes could alter epithelial signaling cascades to promote 
inflammation. However, because the blood rapidly washes this sodium away, it is undetected in 
our examination of total tissue sodium content.  
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Additionally, immune cells in the lamina propria may also be affected by altered 
microgradients or flux of sodium from the colon. In particular, DCs that extend pseudopodia into 
the colonic lumen to sample its contents might also directly experience the new high sodium 
environment. These effects would be exacerbated during inflammation when the epithelial 
barrier becomes more permeable to luminal contents or is effaced.  
How exactly does a HSD exacerbate colitis, or the other immune phenotypes previously 
observed? The first reports demonstrated a role for sodium on the T cell compartment, but 
subsequent studies have also implicated macrophages. Our data now show that DCs respond to 
HSM by expressing additional proIL-1β, IL-6, IL-12, and IL-23, which would be expected to 
drive effector T cell responses in IBD. Indeed, colitis was exacerbated three weeks after 
colonization in the Th1/Th17-driven Il10–/– model, although we did not observe consistent 
elevation in Il17a. This was in contrast to the effect of a HSD upon EAE, which is 
predominantly Th17 driven (19-21, 28). Nevertheless, we examined a time point where clinical 
severity has not yet reached a plateau, so it may be that a HSD will also potentiate Th17 
responses later. Enhanced expression of the myeloid cytokines Il1b as well as Il23a also suggests 
additional effects on innate immune cells. The S. typhimurium model, by comparison, displayed 
enhanced Il17a expression, perhaps originating from ILC3s, along with enhancement of the Il1b 
and Il23a myeloid cytokines. Thus, the data we have presented highlights a novel role for a HSD 
in the DC compartment. 
Placing our data in context with published reports leads one to believe that a HSD 
initiates numerous pro-inflammatory effects on the immune system, which may create a series of 
positive feedback loops. While the high sodium concentration in the colons may have direct 
effects on T cells via the SGK1 mechanism, they may also be driven by the enhanced cytokine 
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production and costimulatory molecule expression of myeloid cells. Simultaneous HSD-
mediated impairment of regulatory T cell function could fuel a pro-inflammatory environment in 
the colon. Future studies could also look at indirect effects of a HSD, which have not currently 
been ruled-out. A HSD could have important effects on the composition of the colonic 
microbiota, or alter the function of certain microbes, as has already been described with the cag 
gene island of Helicobacter pylori (40). Finally, a HSD strongly affects the renin-angiotensin-
aldosterone system (RAAS), inhibition of which has been shown ameliorate murine EAE.(41)  
In conclusion, a HSD generates a high sodium concentration in the colon, which 
exacerbates a murine model of chronic, immune- mediated colitis. Our data may inspire clinical 
studies in humans to determine if dietary salt has detrimental effects on IBD.   
MATERIALS AND METHODS 
Western Diet Salt Concentrations 
Dietary salt was calculated using data from the SELF Nutrition Database (25). Dry 
weight was calculated as the mass of a serving size minus the mass of water. Where the water 
mass was unavailable, the mass of all contents was summed to provide the dry weight. Where 
sodium mass was zero, we assumed 1 mg as an upper limit for calculations.  
Sodium concentration experiments 
Animals were placed on either a HSD or a LSD after day 0 sample collection. Weight, 
food weight, water volume, fecal and urine samples were taken every 12 hours for four days. 
Upon necropsy, serum, urine, feces, all alimentary contents and tissues from the stomach to the 
colon were collected. Solid samples were weighed, dried in a fume hood for ≥72 hours, weighed, 




All liquid samples were separated from debris and diluted 1:100 in 1.5mM CsCl buffer 
for the flame photometer (Model 943 Flame Photometer, Instrumentation Laboratory Co.). 
Briefly, the machine measures minute quantities of sodium and potassium by incinerating a 
laminar flow of the sample solution, creating an ionized gas from which spectra are observed. 
This is translated into a mM concentration readout of ions in the original sample. The original 
concentration of sodium and potassium is then determined by back-calculation: concentration is 
multiplied by the known volume of acid to determine millimoles, and then divided by the volume 
of sample water. 
Animal Diets 
Animal diets were obtained from Harlan Teklad in irradiated, sterile packaging. Animals 
were subjected to either a high salt diet (HSD, TD.92034) of 4% NaCl w/w, or a low salt diet 
(LSD, TD.96208) of .49% NaCl w/w. Animals were permitted standard cage water ad libitum 
during all experiments except where noted.  
IL-10 Animal experiments 
129 SvEv Il10–/– animals and wild-type controls were obtained in germ-free conditions 
from the National Gnotobiotic Rodent Resource Center and transferred to a specific pathogen 
free (SPF) housing facility. Animals were swabbed with slurry of feces from wild-type SPF mice 





Myeloperoxidase and Lipocalin 2 Assays 
MPO and LCN2 were assayed using ELISA kits from R&D Systems (DY3667 and 
DY1857, respectively). Fecal samples were homogenized in PBS containing 0.1% Tween, and 
ELISA values were then standardized against protein content as determined by BCA.  
Tissue Culture 
Bone-marrow derived dendritic cells (BMDCs) from C57BL/6 mice were cultured from 
bone marrow in ultra-low binding polystyrene plates with 10ng/ml IL-4 and G-CSF. Cells were 
preconditioned at least 16 hours prior to use either in normal salt media (DMEM+10% FBS 
+0mM NaCl, NSM) or high salt media (same +40mM NaCl, HSM). Cells were pre-treated for 
30 minutes in the indicated doses of inhibitor, then subjected to 1ng/ml LPS (E. coli, Sigma, 
Cat# L3024). Supernatants were then collected and analyzed by RnD DuoSet ELISAs. SGK1 
inhibitor GSK 650394 (Tocris Biotechne); p38 MAPK inhibitor SB203580 (Invivogen) 
DSS Animal experiments 
SPF C57Bl/6 mice were transferred to either a HSD or a LSD 24 hours prior to DSS 
exposure. Animals were initially fed 3% w/v DSS for 5 days before harvest. Further experiments 
used the initial water consumption rates to calculate DSS concentrations that would normalize 
the dose of DSS/day. Stool samples were taken and tested for fecal occult blood, which was then 
scored based on the degree of biochemical reaction.  
In Vivo Infections 
SPF mice were placed on their diets 48 hours prior to infection. The next day, mice were 
deprived of food and water for four hours prior to gavage with 20mg streptomycin, after which 
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food and water were restored. Salmonella typhimurium SL1344 was grown overnight to an OD 
between 2-6. Cultures were then diluted in PBS to 105 CFU/ml. After 4 hours without food and 
water, mice were gavaged with 100ul of this inoculum, followed by reintroduction of water. 
After 2 hours, food was restored. Feces were collected daily and plated on LB plates containing 
streptomycin and ampicillin.  
Histology 
Cecal tissues were cut from the alimentary tract; colons were cut from cecum to (and 
including) the anus. Tissues were then placed in 10% formalin for at least 24 hours prior to 
embedding, cutting, and H&E staining by the Cell Services and Histology Core. Slides were then 
given to a blinded scorer for assessment.  
Salmonella typhimurium infection: Histology was assessed using a modified scheme 
adapted from Barthel et al (26). Slides were blind scored using a 4-point scale of severity for 
each of four criteria: epithelial hyperplasia and damage; immune infiltrate into the mucosa and 
lamina propria; goblet cell loss; and submucosal edema. 
Il10–/– Model: Blinded histologic scores were assessed using a modified scheme adapted 
from Kim et al. (27). Slides were blind scored using a 4-point scale of severity for each of three 
criteria: epithelial hyperplasia and damage; immune (particularly T cell infiltrate) into the 
mucosa and lamina propria; and goblet cell loss.  
mRNA Expression and Real-Time Quantification 
Tissues for real-time PCR quantification (qPCR) were snap-frozen in RNAlater (Qiagen, 
76106) during harvest and placed at -80C until use. For extraction, tissues were thawed on ice, 
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and homogenized for 10 minutes in a lysis solution containing 1% β-mercaptoethanol and 
RNaseZap (ThermoFisher, AM9780)-treated beads. Extraction proceeded using a PureLink RNA 
mini kit (ThermoFisher, 12183018A). RNA quantified by nanodrop and treated with Turbo 
DNase post elution, with subsequent heat inactivation and reverse transcription. cDNA was run 
on a Life Quantstudio 6 real-time PCR machine using iTaq Universal Sybr Green Supermix 
(Bio-rad). Data were analyzed using the ∆∆CT method with HPRT as the control gene and either 
streptomycin pre-treated mice for Salmonella experiments, or co-transferred gnotobiotic WT 129 







Figure 2.1. A HSD creates a high sodium concentration in the feces. (A) Comparison of the 
NaCl content by dry weight of selected processed and non-processed foods to mouse chow diets, 
from SELF Nutrition Data. (B) Comparison of the NaCl content by weight per volume of 
selected drinks and 0.9-1% NaCl water content. (C-I) Flame Photometric analysis of (C-D) urine, 
(E-F) feces, and (G-H) GI tissues and contents. (E-H) Millimoles of Na+ or K+ are divided by the 
water content of the sample. (I) Milligrams of Na+ or K+ are divided by the dry weight of the 









Figure 2.2. A HSD drives exacerbates histopathologic inflammation in colons of Il10–/– mice. 
GF mice were colonized with SPF fecal microbiota and harvested 21d later. (A-D) 10x 
magnification of representative H&E stained sections of cecal tissue from WT (A,B) and Il10–/– 
(C,D) animals. (E-H) 10x magnification of representative H&E stained sections of colon Swiss 
rolls, oriented with more proximal tissue on the bottom and distal tissue on the top. Boxes 
indicate the location of the insert. (I-J) 20x magnifications of boxed inserts in (G,H) respectively. 
Arrows indicate mononuclear cell infiltration; asterisks indicate crypts where goblet cells have 
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expelled mucus, thus creating an apparent ‘loss’ of goblet cells. Sections shown originate from a 
representative mouse that had histologic scoring at the average histologic score for the group (in 
L,M). Data are representative of 3 replicate experiments. (K) GF mice were colonized with SPF 
feces and fed either a HSD or LSD. Animals were harvested after 3 weeks. (L) Histologic 
scoring of WT and Il10–/– animals for the cecum, proximal colon, transverse colon, and distal 
colon. (M) Combined histologic scores, representing the sum of scores from the cecum and 
colonic regional tissues. (N) LCN2 and MPO ELISA results from feces; results were normalized 
to protein content as determined by BCA assay. P values determined by Mann Whitney 
nonparametric tests, or ANOVA for multiple comparisons; * represents p <0.05. Data are 
combined from 3 (L-M) or 2 (N) replicate experiments. 
 
Figure 2.3. A HSD exacerbates 
colonic cytokine expression in Il10–
/– animals. (A-H) qPCR analysis of 
colonic mRNA from mice in Fig. 3. 
Data were analyzed using the CT 
method against WT controls. (I-N) 
Bone marrow-derived dendritic cells 
(BMDCs) in HSM or normal salt 
media (NSM) were treated with 
1ng/ml LPS for 8 hours before 
indicated cytokines were quantitated 
by ELISA of supernatants or, for 
pro-IL-1, cell lysate (I-L) without, 
or with different concentrations (M) 
of the SGK1 inhibitor GSK 650394 
or (N) the p38 MAPK inhibitor 
SB203580. Samples that failed 
quality control by melt curve 
analysis are omitted. P values 
determined by Mann Whitney 
nonparametric tests. Data are 




















Figure 2.4. A HSD in the DSS model is confounded by sodium in DSS itself. Mice were 
moved to a HSD or LSD and treated with the indicated DSS solutions for 5 days. Mice were 
monitored daily for (A, D) weight, and (B, E) hemoccult score by fecal hemoccult assay. (C, D) 
Mass of DSS consumed daily by each mouse as determined by the percent content of DSS in the 
water and the volume consumed. (G) Flame photometric analysis of 1-5% DSS water. DSS 
vendors: TdB (TdB Consultancy) and MP (MP Biomedicals). Data are from a single experiment 






































Figure 2.5. A HSD exacerbates cytokine expression but not histology or bacterial burdens 
in the S. typhimurium model of colitis. (A) Mice were placed on a HSD or LSD at day -2, 
treated with streptomycin at day -1, and infected with S. typhimurium on day 0, and harvested on 
the indicated day post infection. (B) Combined histological scoring of cecum and colonic tissues, 
as assessed by immune infiltration, goblet cell ‘loss’, epithelial hyperplasia, and edema. (C-J) 
qPCR analysis of cecal mRNA. Data were analyzed using the CT method. * represents p 
<0.05 vs. LSD comparable value by Mann Whitney nonparametric test, and ANOVA test for 






Figure 2.6. S. typhimurium CFU burdens and histology scores. Upper panels display number 
of colony forming units per organ; dashed line indicates limit of detection. Lower panels display 



























Figure 2.7. Effect of a HSD on mRNA expression in caspase-1/11-deficient mice. (A-F) 
qPCR analysis of colonic mRNA from mice infected with S. typhimurium for 3 days. P values 
determined by Mann Whitney nonparametric tests. Data are combined from 2 replicate 











(mg) H2O(g) Dry (g) 
% 
NaCl NaCl w/v 
Vegetables Arugula 2 1 1.8 0.20 1.27  
 Asparagus 134 3 125 9.00 0.08  
 Kidney Beans 184 44 21.6 162.40 0.07  
 
Canned Lima Beans, 
no salt ad 124 5 101 23.00 0.06  
 
Pinto Beans boiled no 
salt 171 2 108 63.00 0.01  
 Broccoli 91 30 81.3 9.70 0.79  
 Brussel Sprouts 88 22 75.7 12.30 0.45  
 Cabbage 89 16 82 7.00 0.58  
 Carrots 128 88 113 15.00 1.49  
 Cauliflower 100 30 91.9 8.10 0.94  
 Celery 110 88 105 5.00 4.47  
 Yellow Corn 166 58 17.2 148.80 0.10  
 Eggplant 82 2 75.8 6.20 0.08  
 Lettuce 5 1 4.5 0.50 0.51  
 Okra 100 8 90.2 9.80 0.21  
 Onions 160 6 143 17.00 0.09  
 Sugar snap peas 72 3 64.3 7.70 0.10  
 Red Potatoes 369 22 299 70.00 0.08  
 White Potatoes 369 22 301 68.00 0.08  
 Spinach 30 24 27.4 2.60 2.35  
 Summer Squash 113 2 107 6.00 0.08  
 Sweet Potato 133 73 103 30.00 0.62  
 Canned Tomatoes 28 37 25 3.00 3.14  
Fruits Apples 125 1 107 18.00 0.01  
 Bananas 225 2 169 56.00 0.01  
 Blackberries 144 1 127 17.00 0.01  
 Blueberries 148 1 125 23.00 0.01  
 Cranberries 110 2 95.8 14.20 0.04  
 Grapes 151 3 122 29.00 0.03  
 Peaches 175 1 155 20.00 0.01  
 Pears 148 1 124 24.00 0.01  
 Pineapple 165 2 142 23.00 0.02  
 Plums 165 1 144 21.00 0.01  
 Raspberries 123 1 105 18.00 0.01  
 Strawberries 152 2 138 14.00 0.04  
 Watermelon 154 2 141 13.00 0.04  
Meats 
Chicken breast, no 
skin 71 46 53.1 17.90 0.65  
 Chicken thigh, no skin 41 35 31.1 9.90 0.90  
 Chicken wing, no skin 17 14 12.7 4.30 0.83  
 Pork tenderloin raw 505 263 379 126.00 0.53  
 
Pork chop or roast 
raw 453 245 268 185.00 0.34  
 
Pork leg (ham) rump 
half raw 453 277 294 159.00 0.44  
 Pork cured unheated 113 1566 71.7 41.30 9.64  
 Ham sliced regular 56 730 37.7 18.30 10.14  
 
Cured pork low 
sodium roast 28 271 19 9.00 7.65  
 Beef raw ground 28 19 18.8 9.20 0.52  
 
Brisket lean only all 
grades 453 358 319 134.00 0.68  
 
Beef short ribs lean 
and fat 453 222 219 234.00 0.24  
 
Beef top sirloin all 
grades 608 316 402 206.00 0.39  
 
Beef tenderloin 
trimmed raw 164 82 101 63.00 0.33  
 
Beef top round all 
grades trim 453 272 313 140.00 0.49  
 
Beef sirloin trim all 
grade raw 261 141 189 72.00 0.50  
 Turkey dark meat raw 132 102 98.3 33.70 0.77  
 Turkey light meat raw 150 94 111 39.00 0.61  
 Raw bacon 28 233 11.3 16.70 3.55  
 Pork sausage 28 142 18.2 9.80 3.68  
Breads Wheat bread 25 130 8.9 16.10 2.05  
 White bread 45 306 16.4 28.60 2.72  
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 Rye Bread 32 211 11.9 20.10 2.67  
 Egg bread 40 197 13.9 26.10 1.92  
 Italian bread 30 175 10.7 19.30 2.30  
 Multigrain bread 26 109 9.6 16.40 1.69  
 Oatmeal bread 27 162 9.9 17.10 2.41  
Grains White short-grain raw 200 2 26.6 173.40 0.00  
 
White rice medium-
grain raw 195 2 25.1 169.90 0.00  
 White glutinous rice  185 13 19.4 165.60 0.02  
 Brown long-grain raw 185 13 19.2 165.80 0.02  
 
Brown medium-grain 
raw 190 8 23.5 166.50 0.01  
 
Dry unenriched egg 
noodle 38 8 3.4 34.60 0.06  
 
Spaghetti unenriched 
dry 57 3 5.6 51.40 0.01  
 Corn pasta 105 3 10.5 94.50 0.01  
Cereals 
Oats regular 
unenriched cooked no 
salt 234 9 196 38.00 0.06  
 Quaker quick oats dry 40 1 3.7 36.30 0.01  
 
Whole wheat hot 
cereal, dry 94 2 9.3 84.70 0.01  
 Cheerios 28 186 1.1 26.90 1.76  
 
Cinnamon toast 
crunch 31 217 0.8 30.20 1.83  
 Corn Chex 31 289 0.8 30.20 2.43  
 Cocoa Puffs 27 144 0.5 26.50 1.38  
 Lucky Charms 35 238 1.1 33.90 1.78  
 Total Raisin Bran 55 240 4.8 50.20 1.22  
 Wheaties 27 189 0.7 26.30 1.83  
 Frosted Mini Wheats 51 5 3.1 47.90 0.03  
 Corn Flakes 28 202 1.1 26.90 1.91  
 Raisin bran crunch 53 209 2.8 50.20 1.06  
 Apple Jacks 33 146 1 32.00 1.16  
 Frosted Flakes 30 139 1 29.00 1.22  
 Raisin bran  59 342 5.2 53.80 1.62  
 Rice Krispies 33 299 1.4 31.60 2.41  
 Post cocoa pebbles 29 157 0.8 28.20 1.42  
 
Post honey bunches 
of oats 31 187 0.9 30.10 1.58  
 Post Raisin Bran 59 289 4.8 54.20 1.36  
 Cap'n Crunch 27 202 0.7 26.30 1.95  
Chick-fil-A 
Chargrilled Chck. 
Gard. Salad 275 620  37.87 4.16  
 
Southwest chargrill 
salad 303 770  51.06 3.83  
 
CG Chick club 
sandwich 221 1240  80.59 3.91  
 CG chicken sandwich 193 940  65.59 3.64  
 
CG chicken salad 
sandwich 153 880  68.10 3.28  
 Chicken Sandwich 170 1300  83.46 3.96  
 
Chicken Deluxe 
Sandwich 208 1300  84.47 3.91  
 Waffle Potato Fries 85 115  50.14 0.58  
 Nuggets 113 1090  51.20 5.41  
 Cole Slaw  220  40.34 1.39  
 Biscuit with Bacon  890  62.97 3.59  
 Biscuit with Sausage  780  85.88 2.31  
 Chicken Biscuit  1270  82.37 3.92  
 Hashbrowns  380  44.41 2.18  
McDonald's 
Bacon, Egg, Cheese, 
Biscuit 142 1225 60.1 81.90 3.80  
 
Bacon Ranch Salad w/ 
Chck 321 1005 261 60.00 4.26  
 Big Mac 219 1007 112 107.00 2.39  
 
Caesar Salad with grill 
chick 311 886 258 53.00 4.25  
 Cheeseburger 119 745 53.5 65.50 2.89  
 McNuggets 64 404 30.4 33.60 3.06  
 
Double 1/4 pounder 
with cheese 280 1333 141 139.00 2.44  
 Egg McMuffin 139 861 76.8 62.20 3.52  
 French Fries 117 266 46.5 70.50 0.96  
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 Hamburger 105 532 48 57.00 2.37  
 Hash browns 56 307 29.5 26.50 2.94  
 Quarter Pounder 171 730 86.1 84.90 2.19  
 Sausage McMuffin 115 797 44.8 70.20 2.89  
 Scrambled Eggs 102 196 68.3 33.70 1.48  
 Cinnamon Roll 105 397 21.4 83.60 1.21  
Burger King Cheeseburger 133 801 59.3 73.70 2.76  
 
Double whopper with 
cheese 399 1544 213 186.00 2.11  
 French Fries 117 532 42.9 74.10 1.83  
 Hamburger 121 550 54.1 66.90 2.09  
 Hash Brown Rounds 77 394 27.8 49.20 2.04  
 Whopper with cheese 316 1432 174 142.00 2.56  
 
Croissant. with sauce, 
egg, cheese 157 1090  83.60 3.31  
 French Toast Sticks  440  72.50 1.54  
 
Sourdough Breakfast 
Sandwich with Bacon, 
Egg and Cheese 130 990  69.43 3.62  
 
Chicken Caesar 
without dressing and 
croutons 257 730  36.88 5.03  
 Chili  1040  39.18 6.75  
Taco Bell Bean Burrito 198 1216 109 89.00 3.47  
 
Burrito Supreme with 
Steak 248 1324 152 96.00 3.51  
 Nachos Supreme 195 838 105 90.00 2.37  
 
Original Taco with 
Beef 78 349 43.6 34.40 2.58  
 
Soft Taco with 
Chicken 99 600 55.9 43.10 3.54  
 Taco Salad 533 1935 359 174.00 2.83  
 Breakfast Burrito 239 1540  93.23 4.20  
 Mexican Pizza 215 1050  99.35 2.69  
Cheese Blue Cheese 17 237 7.2 9.80 6.15  
 Cheddar Cheese 132 820 48.5 83.50 2.50  
 Colby Cheese 132 797 50.4 81.60 2.48  
 
1% low fat cottage 
cheese 226 918 186 40.00 5.83  
 Cream Cheese 232 745 126 106.00 1.79  
 Feta Cheese 150 1674 82.8 67.20 6.33  
 Gouda Cheese 198 1622 82.1 115.90 3.56  
 Monterey Cheese 132 707 54.1 77.90 2.31  
 
Nonfat Mozzarella 
Cheese 113 840 68 45.00 4.75  
 
Hard Parmesan 
Cheese 10 164 3 7.00 5.96  
 Provolone Cheese 132 1156 54 78.00 3.77  
 Whole Milk Ricotta 246 207 176 70.00 0.75  
 Swiss Cheese 132 253 49 83.00 0.77 NaCl w/v 
Juice 
Grape juice canned or 
bottled 253 13 214 39.00 0.08 6.07E-05 
 
Apple juice canned or 
bottled 248 10 219 29.00 0.09 4.57E-05 
 Cranberry juice 253 5 220 33.00 0.04 2.27E-05 
 Orange juice 249 10 218 31.00 0.08 4.59E-05 
Dairy Whole Milk 244 98 215 29.00 0.86 0.000456 
 1% Milk 244 107 219 25.00 1.09 0.000489 
 2% Milk 244 100 218 26.00 0.98 0.000459 
Alcohol Table red wine 29 1.5 25.3 3.70 0.10 5.93E-05 
 Table white wine 29 1.5 25.4 3.60 0.11 5.91E-05 
 Regular Beer 30 1.2 27.1 2.90 0.11 4.43E-05 
Soda Generic Orange Soda 31 3.7 27.2 3.80 0.25 0.000136 
 Generic Cola 30 1.2 27.5 2.50 0.12 4.36E-05 
 Generic Ginger Ale 30 2.1 27.8 2.20 0.24 7.55E-05 
 Generic Grape Soda 31 4.6 27.5 3.50 0.33 0.000167 
 
Generic Lemon Lime 
Soda 30 3.1 27.5 2.50 0.32 0.000113 
 
Generic pepper-type 
soda 30 3 27.3 2.70 0.28 0.00011 
 Generic Root Beer 30 4 27.5 2.50 0.41 0.000145 
 
Sprite lemon-lime 
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CHAPTER 3: CASPASE-1 CLEAVES CASPASE-7 TO INITIATE IEC EXFOLIATION3  
 
SUMMARY 
The gastrointestinal tract is the largest epithelial surface of the body and is also one of the 
most susceptible to infection and disorders. In order to defend itself, recent reports have shown 
that intestinal epithelial cells (IECs) directly express a number of inflammasomes and are 
capable of initiating pyroptosis and exfoliation from the monolayer(1, 2). However, the 
mechanism by which these cells exfoliate is unknown. While previous reports argue for the 
importance of caspase-3, the traditional executioner caspase of apoptosis in this process, little 
attention has been paid to the less well studied caspase-7(3-5). Here, we find that caspase-7 in 
intestinal epithelial cells is rapidly cleaved after infection by Salmonella enterica serovar 
Typhimurium, leading to exfoliation in a manner independent of caspase-3 cleavage. We show 
that failure to exfoliate IECs results in outgrowths of S. typhimurium microcolonies on the 
epithelium and worsened colonic pathology. Further, we demonstrate the physiologic importance 
of the ability of caspase-1 to cleave caspase-7 in vivo, and that caspase-7 subsequently cleaves 
gelsolin to initiate cytoskeletal dismemberment prior to exfoliation. These results provide a novel 
                                                          
3 This chapter contains unpublished data assembled so as to convey a meaningful perspective on 
our work on caspase-7. As such, this chapter includes data collected by a previous post-doctoral 
fellow, M. Rayamajhi for story-telling purposes, and references data from K Nozaki not 
displayed. M. Rayamajhi contributed to panels of Figures 3.2g, 3.3e, 3.3f, and 3.5e, and entirely 
comprise Figures 3.2b, 3.2d, 3.2e, 3.2f, 3.3c, 3.3d, 3.5a, 3.5b, 3.5c, and 3.5d.    
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explanation for the functional differences between caspases-3 and -7 and argue that caspase-7 is 




The gastrointestinal tract is the largest epithelial organ of the body, and as such, is 
exposed to numerous dangers. These can include pathogens from every domain of life, including 
bacteria (e.g. Salmonella, Listeria, Shigella, Campylobacter, Clostridium difficile, 
Enteropathogenic and Enterohemorrhagic E. coli, Vibrio), viruses (e.g. Poliovirus, Norovirus, 
Rotavirus, Adenovirus, Astrovirus), fungi (e.g. Aspergillus spp, Candida albicans), protists (e.g. 
Giardia, Blastocysis, Cryptosporidium, Entamoeba), helminths (e.g. Ascaris, Cestoda, Taenia), 
flukes (e.g. Fasciolopsis, Schistosoma), and round worms (e.g. Ancyclostoma, Anisakiasis, 
Enterobius, Trichinella, Trichuris). However, the intestine must also contend with numerous 
environmental hazards, such as small molecules (e.g. drugs, microbiota byproducts), nutritional 
macromolecules (e.g. amino acids, vitamins), nutritional byproducts (e.g. maillard reaction 
advanced glycation endproducts), toxic biologics (e.g. bacterial toxins or genotoxins), minerals 
(e.g. sodium, iron), and anthropogenic compounds (e.g. colorants, preservatives, plastics). Thus, 
sources of danger or damage must be rapidly sensed and ameliorated before either can interfere 
with intestinal functions.  
To accomplish the required rapid responses, the gut employs a number of innate immune 
defenses, some unique to the organ and some common, and each capable of quickly responding 
to foreign or resident stimuli. For example, numerous monocytes undergird the epithelial barrier, 
and either sample the lumen directly, or acquire samples from M cells or other mechanisms, thus 
enabling surveillance of the intestinal environment (6). Similarly, a number of innate lymphoid 
populations exist in the gut and presumably survey the intestinal epithelial cells (IECs) and the 
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lamina propria environment.  One such population is the poorly characterized cytotoxic 
intraepithelial lymphocyte (IEL), which is present at a staggering ratio of 1 IEL: 10 IECs (7, 8), 
and interdigitates between epithelial cells constantly (9). Another population are the numerous 
kinds of innate lymphocytes (ILCs), which can quickly initiate their pre-programmed lineage-
specific functions and are important for gut homeostasis (10-12).  
However, we are also beginning to appreciate that epithelial cells themselves play 
significant innate immune defensive functions. IECs produce the barrier-forming mucins, release 
antimicrobial peptides, and can secrete cytokines and chemokines in their own right. In addition, 
though lacking in most external pattern recognition receptors like the TLRs, IECs express a 
number of intracellular sensors, including several inflammasomes. Defined as intracellular 
sensors that engage caspase-1, inflammasomes are capable of detecting numerous stimuli, 
including manipulation of the cell (e.g. Pyrin (13)), or virulence factor contamination of the 
cytosol (e.g. NLRC4 (1)).  When an inflammasome binds its target ligand, it engages the cell-
death protease caspase-1, either directly through CARD-CARD domain interactions, or 
indirectly through PYD-PYD interactions with the adaptor ASC. Once activated, caspase-1 
proceeds to cleave the highly inflammatory pro-IL-1β and pro-IL-18 cytokines into their mature, 
active forms, and lyse the cell by cleaving gasdermin D (14). Upon cleavage, gasdermin D 
inserts into the outer membrane forming a pore, executing the lytic, programmed, and highly 
inflammatory cell death pyroptosis (15).  
Interestingly, IECs not only basally express inflammasomes and caspase-1, but also 
gasdermin D, the uncharacterized gasdermins C1-4 (gasdermin C in humans), and pro-IL-18 (16-
18). Indeed, previous work has demonstrated that these inflammasomes are fully functional in 
IECs, and can lead to cell extrusion from the monolayer (1). One tool to examine this is FlaTox, 
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a modification of the anthrax Lethal Toxin AB toxin system that uses a fusion of the anthrax 
Lethal Factor n-terminus (LFn) to FlaA flagellin from Legionella pneumophila, enabling 
delivery of FlaA directly to the cytosol by Protective Antigen (PA), and thus direct activation of 
NLRC4 (19). Intravenous treatment with FlaTox  in mice causes epithelial cells of the small 
intestine to become PI positive (indicating pore-formation) and slough into the lumen. At the 
time, this latter sloughing function was observed in both Casp1–/– and Gsdmd–/– mice, suggesting 
that exfoliation was independent of caspase-1 and gasdermin pore formation. Instead, exfoliation 
in these mice was dependent on the activity of caspase-8, which was engaged by an alternate 
NLRC4→ASC→caspase-8 pathway. This was also shown to be true in IEC-only organoids 
treated with FlaTox (2). Thus, IECs that detect virulence (e.g. the translocation of flagellin into 
their cytosol) are capable of responding by quickly sloughing into the lumen and removing 
themselves and any pathogens they harbor from the epithelial barrier.  
One pathogen that might activate this pathway is the enteric bacterium Salmonella 
enterica serovar Typhimurium. S. Typhimurium uses a T3SS called SPI-1 to inject epithelial 
cells with effectors that use villin and rho GTPases to remodel the cytoskeleton (often visualized 
as a ‘membrane ruffle’) and enable entry into a vacuole within the IEC (20, 21). Components of 
this SPI-1 T3SS, such as PrgJ, and PrgI, as well as flagellin FliC are readily detected by NLRC4, 
and are thought to be accidentally translocated by SPI-1 into the host cytosol, enabling such 
detection (22-24). Indeed, previous work has demonstrated that S. Typhimurium infection results 
in rapid epithelial cell sloughing, where infected cells retained bacteria expressing components 
of SPI-1 – this was interpreted as preparing bacteria for subsequent reinvasion. These sloughed 
cells were noted to be both caspase-1 activated (which corroborates the previous FlaTox data), as 
well as caspase-3/7 activated, as determined by a cleavable fluorescent substrate specific for 
 
59 
either -3 or -7 (25). Since caspase-3 is known to mediate many cell-death phenotypes, and is 
cleaved by caspase-8, caspase-3 seems the obvious choice for executing cell-sloughing 
functions. However, data also show that caspase-7 can initiate detachment of cells and thus 
potentially precipitate sloughing (4). Thus, we set out to determine which caspase was important 
for cell-sloughing: caspase-3 or caspase-7. 
RESULTS  
 
While caspase-3 is widely expressed throughout the body, caspase-7 appears to have a slightly 
more limited distribution. As a result, we began by investigating whether intestinal tissues 
expressed appreciable quantities of caspase-7. Surprisingly, from a list of several tissues 
extracted from BioGPS, caspase-7 expression was high in epithelial tissue such as the small and 
large intestine, the stomach, and the uterus (Fig. 3.1a, (17)), as well as in certain cell types such 
as macrophages (data not shown). This mirrored caspase-3 expression, which was also high in 
these tissues, as well as in the bone marrow. However, upon closer examination of IEC-specific 
expression data sets available via NCBI’s GeoDatasets repository, we found that C57BL/6 IECs 
expressed more caspase-7 than -3 (18), and the difference was even more pronounced in BALB/c 
IECs, where caspase-3 expression was only slightly above genes that are known to be not 
expressed by IECs (e.g. hematopoietic CD45, thymic Aire, and neuronal/hepatic stellate cell 
Gfap) (16).  
These data suggested that the heretofore unknown specific function of caspase-7 may be 
particularly important in IECs as a cell type. To investigate this, we decided to examine caspase-
7-deficient mice and heterozygous littermate controls on the C57Bl/6 background in the DSS 
model of colitis. While the precise mechanism of DSS is unclear, treatment gradually leads to 
ulceration of the epithelium and intestinal inflammation. Intriguingly, Casp7–/– mice lost weight 
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more rapidly and more severely than littermate counterparts and recovered more slowly when 
taken off DSS (Fig. 3.2b). This was also correlated with exacerbated pathology at day 9 (Fig. 
3.2c and d). These results suggest that caspase-7, independently of caspase-3, may have 
functions in intestinal homeostasis or repair.  
Both caspases-7 and 3 are known to be cleaved by the apoptotic initiator caspase-8. 
However, because caspase-3 activation is sufficient to initiate apoptosis, and Casp3–/– mice are 
embryonically lethal on some backgrounds (26), caspase-7 has come to be regarded as an 
inefficient backup for caspase-3 (27-30). In IECs, cells extruding from the monolayer under 
homeostatic conditions stain positive for cleaved caspase-3 (3), and similarly, cells sloughing 
from a S. typhimurium-infected polarized monolayer had cleaved a caspase-3/7 fluorescent 
substrate, suggesting they were initiating apoptosis (25).  
To determine if caspase-7 was also playing a role in this process, we infected mice and 
examined cecal IECs over a time course. Surprisingly, at 6 hours, many of the cells extruding 
from the monolayer stained brightly for cleaved caspase-7, even when bacteria were not visible 
(Fig. 3.2e). By 12 hours, bacteria were visible infecting both the monolayer, as well as exfoliated 
cells – the latter of which often lacked distinct phalloidin staining (i.e. distinct actin structure), 
but stained positive for cleaved-caspase-7 (Fig. 3.2f). When comparing WT and Casp7–/– mice 
directly, by 24 hours fewer exfoliating cells were visible, but whereas WT mice had relatively 
few bacteria attached to their epithelial surface, Casp7–/– appeared to harbor large microcolonies 
of S. Typhimurium (Fig. 3.2g). Finally, at 48 hours, both tissues harbored numerous exfoliating 
cells, but whereas WT cells stained positive for CC7+ and weakly for actin, Casp7–/–   cells 
appeared to have sloughed in a disorganized fashion, and retained strong actin banding on their 
exteriors (Fig. 3.2h).  
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These data suggested that caspase-7 appeared to play a role in intestinal cell exfoliation, 
as it was present in sloughing cells and absence led to aberrant bacterial colonization and actin 
staining. However, and the mechanism of caspase-7 activation and its function in defense 
remained unclear.  
Previous studies have shown that caspase-3 can cleave caspase-7 after activation, as well 
as direct cleavage by caspase-8. In addition, other groups have shown in vitro that caspase-1 can 
cleave caspase-7 directly (31), and may also cleave caspase-8 in the right conditions (32). 
Finally, external activation is possible through perforin-mediated delivery of granzyme B, which 
cuts both caspases-3 and -7 directly (33-35). We therefore set about examining how caspase-7 
was being activated at these time points.  
The rapid activation of caspase-7 only 6 hours after infection suggested that a cell-
intrinsic mechanism was at play. Nevertheless, it is possible that cytotoxic IELs drive exfoliation 
in some contexts. However, Prf1–/– mice examined at 24 hours did not exhibit bacterial 
microcolonies compared to Casp7–/– mice (Fig. 3.3a) and continued to exhibit CC7+ exfoliated 
cells at 48 hours compared to WT (Fig. 3.3b). In addition, Rag1–/– mice which lack IELs 
similarly did not harbor microcolonies 24 hpi (K Nozaki in Miao lab, unpublished), thus 
reducing the likelihood of an extrinsic mechanism of caspase-7 activation in IECs.  
Caspase-3 is both important for cell exfoliation under homeostatic conditions and is 
known to cleave caspase-7 directly. However, to our surprise, while infection significantly 
increased the number of CC7+ cells per field, the number of cleaved caspase-3 (CC3+) cells did 
not change 6 hpi compared to uninfected controls (Fig. 3.3c). Similarly, the loss of caspase-3 did 
not affect the number of CC7+ cells 6 hpi (Fig. 3.3d), suggesting that caspase-3 activation was 
not required for caspase-7 activation. Likewise, while Casp7–/– mice exhibited worse pathology 2 
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dpi compared to WT mice, possibly due to the disorganized cell exfoliation seen before (Fig. 
3.2h), the presence or absence of caspase-3 did not affect pathology (Fig. 3.3e). This pathology 
was correlated with increased IL-18, which is known to be pathologic in the intestine (36). 
Upon activation, the apoptotic initiator caspase-8 is well known to cleave caspase-7. 
More recently, caspase-1 was shown to cleave caspase-7 in a cell-free system, and numerous 
caspase-1 activating stimuli lead to caspase-7 cleavage in vitro (37). In contrast, caspase-1 was 
dispensable for caspase-3 activation in the same system. In another report, loss of caspase-1 after 
NLRP3 inflammasome activation resulted in delayed caspase-8 cleavage kinetics, suggesting 
that that caspase-1 can cleave caspase-8, which might then cleave caspase-7 (32). Finally, recent 
work has demonstrated that inflammasomes acting through ASC can activate caspase-8, leading 
to extrusion even in the absence of caspase-1 (2). Thus, to parse the roles of caspases-1 and -8 in 
caspase-7 activation, we began by infecting macrophages in vitro with late log-phase S. 
Typhimurium, which are known to rapidly induce caspase-1, and probed for caspase activation. 
As expected, cells lysed in a caspase-1-dependent manner within 30 minutes of infection. 
Interestingly, caspase-1 appeared to directly cleave caspase-7, as cleaved caspase-7 was 
observed within 30 minutes of infection, albeit weakly, and in the absence of either cleaved 
caspases-3 or -8 (Fig. 3.4a.). Indeed, this cleavage was delayed in Casp1–/–Casp11–/– 
macrophages, indicating that caspase-1 was required for early activation. Similarly, treating 
macrophages with PrgJTox (similar to FlaTox but delivers Salmonella PrgJ to the cytosol rather 
than Legionella FlaA to activate NLRC4 (19)) again resulted in rapid caspase-7 cleavage in the 
absence of cleaved caspases-3 or -8, particularly if pyroptosis was delayed by adding glycine to 
the media (Fig. 3.4b). This suggested that caspase-1 activation alone, and not other effects due to 
bacterial infection lead to the cleavage of caspase-7.  
 
63 
To test whether this same inflammasome circuit was present in intestinal epithelial cells, 
we performed a preliminary experiment treating small intestinal tissues ex vivo with FlaTox. 
Surprisingly, WT tissues stained positively for cleaved caspase-7 within as little as 20 minutes, 
and IECs rapidly exfoliated from these tissues, denuding the explants by 1 hour (Fig. 3.4c). In 
contrast, Casp7–/– tissues retained their morphology throughout the timecourse. Finally, while 
Nlrc4–/– tissues were mostly resistant, there appeared to be some spontaneous caspase-7 
activation, suggesting that caspase-7 may be rapidly cleaved in the intestine following 
hyperphysiologic stresses, such as hypoxia from being removed ex vivo. In consequence, even 
tissues treated with PBS eventually activated caspase-7 and began to exfoliate by 1 hour, while 
the Casp7–/– mice retained exfoliation resistance (data not shown).  
In vivo, we previously observed that infecting Casp7–/– mice resulted in epithelial 
microcolonies by 24 hours, and disorganized, actin-rich cell exfoliation by 48 hours (Fig. 3.2g-
h). To test whether caspase-1 stimulation was involved, we infected mice with invG::Tn5lacZY 
mutant S. Typhimurium, which cannot construct a SPI-1 T3SS (SPI-1mut). Interestingly, both WT 
and Casp7–/– mice developed microcolonies at 24 hours, suggesting that caspase-1 activation was 
required for preventing microcolony formation (Fig. 3.4d). We also tested a phoP::Tn10dCm 
mutant; phoP is the regulatory component of the phoP/phoQ response-regulator, which may 
sense antimicrobial peptides and vacuolar acidification, leading to modification of LPS to avoid 
antimicrobial peptide binding and repression of the SPI-1 T3SS. Thus, we hypothesized that 
phoPmut bacteria may be uniquely unable to form microcolonies by failing to defend itself from 
AMPs, or by over-stimulating caspase-1-mediated expulsion with uncoordinated SPI-1 
expression in permissive Casp7–/–  mice. Indeed, these bacteria failed to form microcolonies 
regardless of mouse genotype (Fig. 3.4e). These data suggest that caspase-1 activation is 
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sufficient to activate caspase-7-dependent defenses, and that Salmonella may have adapted to 
these defenses of the adherent epithelial niche by coordinating AMP-sensing with suppression of 
the caspase-1-activating SPI-1. 
While caspase-1 can cleave caspase-7 in vitro, the physiological relevance of this 
cleavage remained unknown in vivo. Caspase-1 cleaves the cytokines proIL-1β and proIL-18 to 
their mature forms, and initiates pyroptosis by cleaving gasdermin D. Although the restriction of 
caspase-7 expression in various tissues suggested that it had tissue-specific function downstream 
of caspase-1, we sought to test whether caspase-7 played an underappreciated role in previous 
caspase-1-mediated systemic defense. As expected, infection of macrophages with late log-phase 
(SPI-1IND) S. Typhimurium induced pyroptosis in a MOI dose-dependent fashion independent of 
the presence or absence of caspase-7 (Fig. 3.5a). Similarly, we have previously shown that 
induction of pyroptosis by over-expression of the flagellin monomer FliC leads such FliCON 
bacteria to be rapidly outcompeted by WT bacteria in vivo. Again, caspase-7 played no role in 
this process (Fig. 3.5b), and WT and Casp7–/– mice had no significant difference in splenic 
burdens during systemic infection (Fig. 3.5c). We also tested whether caspase-7 was required for 
systemic protection downstream of the closely-related caspase-11, which detects cytosolic LPS 
(38) and cleaves gasdermin D (14). As before, macrophages readily initiated pyroptosis upon 
introduction of LPS to the cytosol by cholera toxin B (CTB, Fig. 3.5d), were completely resistant 
to challenge with the caspase-11-cleared pathogen Burkholderia thailandensis, readily clearing 
systemic organs (Fig. 3.5e) (39, 40). Therefore, caspase-7 is activated by caspase-1 (as shown in 
Fig. 3.4). However, this activation event may or may not be useful against pathogens, depending 
on the nature of the infection.  In infectious models where we think that macrophages are the 
primary infected cell type (FliCON and B. thailandensis), caspase-1 or -11 accomplish defense 
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without the need for the caspase-7 function (it is likely activated, but that activation is neither 
useful nor harmful; Fig. 3.5). However, in IECs, the activation event is useful, as loss of 
exfoliation leads to outgrowth of adherent microcolonies (Fig. 3.2g) and worsened intestinal 
pathology (Fig. 3.3e).  
To directly determine whether caspase-1 was upstream of caspase-7 in vivo, we infected 
Casp1–/–Casp11–/– mice and examined cecal tissues for microcolonies and sloughing. 
Unexpectedly, these mice lacked bacterial microcolonies and looked like WT mice, despite 
having increased cecal tissue burdens (Fig. 3.6a, data not shown). Even more strikingly, 48 hpi, 
these mice displayed reduced levels of cleaved caspase-7 activation and fewer sloughed cells 
than WT mice (Fig. 3.6b). These data suggest that caspase-1 and caspase-7 do not exist in a 
simple linear relationship, thus driving us to consider a model of caspase-7 activation from 
multiple sources (Fig 3.1). As noted above, the simplest, and likely fastest acting pathway is 
NLRC4→caspase-1→caspase-7, which explains the 30 minute activation of caspase-7 after S. 
Typhimurium infection in WT, but not in Casp1–/–Casp11–/– macrophages (Fig. 3.4a). However, 
previously published data has already established that NLRC4 can eventually lead to activation 
of caspase-8 via the adaptor ASC (2), thus postulating a slower backup pathway of 
NLRC4→ASC→caspase-8→caspase-7 and caspase-3.  This in turn would explain the delayed 
activation of caspase-7 in the Casp1–/–Casp11–/– macrophages observed in Fig. 3.4a.  
If this relationship is true, we postulated that direct activation of NLRC4 by FlaTox in 
our small intestinal explant model would lead to a delay in exfoliation in Casp1–/–Casp11–/– mice 
relative to WT, but not as complete protection as loss of caspase-7 entirely. Indeed, as 
hypothesized, Casp1–/–Casp11–/– small intestines treated with FlaTox delayed caspase-7 
activation, but eventually sloughed like WT by 1 hour (Fig. 3.6c). Similarly, we found that 
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Nlrc4–/– mice harbored microcolonies similar to Casp7–/– mice, supporting the notion that 
caspase-1 is only one part of the activation pathway of caspase-7, and can be circumvented by 
NLRC4-dependent activation of caspase-8 (personal communication, K. Nozaki and E. Miao). 
Returning to in vitro, we either infected Casp1–/–Casp11–/– macrophages with SPI-1-induced S. 
Typhimurium (Fig. 3.6d), or with PrgJ-Tox (data not shown), and probed for late caspase-7 
activation independent of caspase-1. As expected, cleaved caspases-8, -7, and -3 were detected 
later after infection or treatment, and this cleavage was abrogated if macrophages were pre-
treated with LPS (which is known to inhibit caspase-8 activity by inducing expression of 
caspase-8 inhibitor c-FLIPL (41)).  
These data argue that inflammasomes can activate caspase-7 both in vitro and in vivo, in 
both macrophages and in IECs. Further, the activation of caspase-7 appears to be correlated with 
exfoliation of IECs, required for protection against adherent bacterial microcolonies, and 
cytoskeletal rearrangements of sloughing cells. However, the direct functions of caspase-7 on 
exfoliation are unknown. To test this, we grew organoids from WT or Casp7–/– mice and treated 
them with FlaTox. As previously published, WT organoids rapidly stained positive for 
propidium iodide (indicating gasdermin D pores had formed) and exfoliated, resulting in 
involution of the organoids. However, Casp7–/– took up PI but did not involute (K. Nozaki and E. 
Miao, personal communication). Thus, Casp7–/– appears to be necessary for IEC exfoliation. 
Because Casp7–/–  IECs that had sloughed from the epithelium at 48 hours displayed marked 
retention of actin structures (as visualized by c-shaped phalloidin staining, Fig. 3.2h), we 
hypothesized that caspase-7 might cleave and activate actin-severing proteins such as gelsolin. 
Gelsolin is known to contain an apoptotic caspase cleavage site, and upon cleavage it rapidly 
severs actin and, under certain conditions, cap actin filaments, resulting in loss of actin networks. 
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Returning to our in vitro stimulations, we found that gelsolin, but not flightless-I (a related 
gelsolin family member), was cleaved after caspase-7 activation at both the early, caspase-1 
dependent timepoints (Fig. 3.6e), and the late, caspase-8-dependent time points (Fig. 3.6d; 
flightless I data not shown). This is consistent with rapid exfoliation, as transfection of cleaved 
gelsolin alone can cause cells to detach in vitro (42). Gelsolin cleavage by caspase-7 could 
explain why Casp7–/– mice have very delayed IEC exfoliation during S. Typhimurium infection, 
and why in this delayed event the IECs maintain polymerized actin. Although published work 
shows that gelsolin cleavage is sufficient to cause detachment in vitro, it remains to be 
determined whether gelsolin cleavage is sufficient to cause IEC exfoliation in vivo, and whether 
gelsolin cleavage is necessary for caspase-7 to drive IEC exfoliation in vivo.  
Taken together, our work demonstrates that caspase-7, and not caspase-3, is required 
downstream of NLRC4 agonists to drive exfoliation of IECs. This can be driven by NLRC4-
caspase-1 activating caspase-7 quickly, or by a NLRC4-ASC-caspase-8 pathway activating 
caspase-7 more slowly. Although we do not currently have the exact caspase-7 cleaved proteins 
that are necessary and sufficient to drive exfoliation, one candidate is gelsolin, whose activation 
by cleavage can dissolve the actin cytoskeleton.  As a result, infected IECs can exfoliate in a cell 
intrinsic manner, preventing the formation of adherent bacterial microcolonies and exacerbated 




 Inflammasomes are intracellular sensors of damage or disease that initiate potent immune 
defenses, including the cleavage of IL-1β and IL-18 into their active forms, and the cleavage of 
gasdermin D to initiate lytic, inflammatory cell death (43). While first characterized in the 
hematopoietic compartment, data now show that these defenses are also expressed in intestinal 
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epithelial cells (IECs), that S. Typhimurium and FlaTox can activate these defenses, and that 
activation by either leads to exfoliation of the epithelial cell (1, 2). This last process was 
determined to be independent of gasdermin D, and in fact relied upon a backup pathway between 
the inflammatory caspases and the apoptotic initiator caspase-8 (2). Now, we show that 
exfoliation downstream of inflammasome activation does not solely rely on caspase-8 activation, 
but rather on specific cleavage of caspase-7, either by caspase-1 or caspase-8.  
 Apoptotic caspases are classified as either initiators or executioners. Among 
executioners, caspase-3 is the primary executioner of apoptosis and caspase-7 is thought of as an 
inefficient backup executioner (27, 30).  Indeed, caspase-7-deficient mice are wholly viable and 
appear to suffer no developmental deficits. In contrast, Casp3–/– are embryonic lethal on the 129 
background, where they suffer neurologic and developmental defects (26). Surprisingly Casp3–/– 
mice are viable on the C57BL/6 background but the Casp3–/–Casp7–/– are not viable, leading to 
the idea that caspase-7 acts as a backup for caspase-3, but one that sometimes works and 
sometimes does not (28).  In consequence of these and other studies, the apoptosis field generally 
considers caspase-7 and its similarly poorly characterized homologue caspase-6 to be inefficient 
backups of caspase-3. Indeed, caspase-7 is reported to cleave many of the same substrates as 
caspase-3 – some less efficiently – with only few specific targets of its own (27, 44-47). 
Nevertheless, our data now illustrate two major distinctions between caspase-7 and caspase-3. 
First, while it had been demonstrated in vitro (37), we now show that caspase-7 is cleaved by 
caspase-1 in vivo. Secondly, we show that caspase-7 cleavage by caspase-1 leads to exfoliation 
of epithelial cells in the absence of caspase-3. Thus, caspase-7 represents a remarkable fusion of 
an inflammatory initiator caspase (caspase-1) and what has traditionally been considered an 
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apoptotic executioner caspase (caspase-7) in defense against the intestinal pathogen S. 
Typhimurium.  
 The advantages of this union are immediately obvious. Inflammasomes detect infection, 
and initiate caspase-1-dependent lytic cell death and cytokine release.  In contrast, caspase-3 is 
known to initiate detachment of epithelial cells as a prelude to apoptosis under homeostatic 
conditions (3). Similarly, studies of serum-starved MEFs demonstrated that caspase-7 deficiency 
also delayed detachment (4). Now, we find that inflammasomes in IECs can combine their cell 
death and cytokine release functions with the apoptotic detachment capacity of caspase-7 to 
expel the infected, dead cell from the host. The importance of this contribution to 
inflammasome-mediated defense in IECs is illustrated by the fact that even under heightened IL-
18 secretion and presumed loss of membrane integrity, the failure to exude such infected cells 
results in a permissive niche for S. Typhimurium to form adherent microcolonies (Fig. 3.2g).  
 Despite these results, one may wonder why caspase-1 cleaves caspase-7 in order to 
achieve this outcome; that is, what evolutionary pressures led to the duplication event upstream 
of caspase-7, rather than directly linking the two pathways by having caspase-1 directly activate 
caspase-3? One possible explanation is that caspase-7 may be more efficient at exfoliating cells 
than caspase-3. For example, caspase-7 has been shown to cleave focal adhesion kinase (FAK) 
100 times more efficiently than caspase-3 (45). Since FAK is a critical regulator of focal 
adhesions between cells, this could be another mechanism by which caspase-7 drives detachment 
(perhaps in parallel to gelsolin cleavage). Thus, caspase-7 may cleave many targets associated 
with cytoskeletal dismantling and exfoliation more efficiently than caspase-3. Alternatively, 
caspase-7 may have many of the same substrate-specificities as caspase-3, but may be localized 
to the plasma membrane as has been previously shown (48). Thus, caspase-7 may disassemble 
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focal adhesions far more efficiently than caspase-3, which may be diffuse throughout the cytosol 
and unable to rapidly cleave focal adhesion molecules. Indeed, we found that caspase-7 contains 
a quad-positive charge motif (KKKK) in the n-terminal region of the protein that may serve as a 
membrane-localization signal. In this hypothetical situation, the result would be an IEC that 
delays exfoliation perhaps by 2 hours – which, when considering that S. Typhimurium that can 
double in as few as 20 minutes in the lumen, may be the difference between the presence or 
absence of a microcolony in our mice. Finally, caspase-7 may be able to initiate its effects 
without interfering in pyroptotic death, or in a way that augments pyroptosis. For example, a 
previous study of NLRC4 activation in epithelial cells showed that epithelial cells slough before 
they released their cytoplasmic contents (in this case, RFP) (1), suggesting that caspase-7-
mediated exfoliation may even occur faster than gasdermin-mediated pyroptosis.  
 A second question is whether gelsolin is the only target of caspase-7 necessary for 
mediating exfoliation. Previous work has shown that transfection of activated gelsolin alone into 
a cell results in detachment from the plate (42) ; thus gelsolin is sufficient to cause detachment. 
However, it is likely that caspase-7 cleaves many targets to mediate its effects; as noted above, 
FAK is cleaved very specifically by caspase-7, and cleavage may prevent FAK from repairing 
focal adhesions, thus facilitating exfoliation. We are also entertaining the possibility that 
additional caspase-7 specific targets exist; if these are other members of the focal adhesion 
complex, caspase-7 could systematically disassemble focal adhesions by cleaving multiple 
proteins in the complex. Finally, other specific targets of caspase-7 may similarly facilitate 
epithelial cell sloughing. Future work will need to examine the effects of cleaving gelsolin, FAK, 
and caspase-7 directly in epithelial cells without the concomitant activation of caspase-1 and 
ASC-mediated caspase-8 cleavage inherent to S. Typhimurium infection or FlaTox treatment.  
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 Likewise, caspase-1 is likely not the only pathway to caspase-7 activation in epithelial 
cells. Previous work demonstrated that infection with S. Typhimurium led to exfoliation of cells, 
some almost all of which cleaved a caspase-3/7 substrate, but only a portion of which had 
similarly activated caspase-1. Indeed, our observations found that there were significantly more 
cleaved caspase-7+ cells 6 hours post infection than uninfected, even when bacteria were not 
visible (Fig. 3.2e). While it is possible that these bacteria were simply out of the plane of focus, 
these data suggest that other mechanisms may lead to caspase-7 activation in IECs. One obvious 
mechanism is perforin-mediated delivery of granzyme B by CTLs or NK cells, as granzyme B 
can cut both caspases-3 and -7, though other death mechanisms (e.g. Fas-Fas ligand interactions) 
may eventually provide the same result) (35). Indeed, we have recently shown that CTL-
mediated granzyme B delivery activates caspase-7 in hepatocytes and is necessary for clearance 
of several pathogens (Maltez, Mitchel, Tubbs et al., submitted for publication). The pathways 
that can initiate caspase-7 activation in hepatocytes are simplified, as these cells do not express 
caspase-1 (49), thus eliminating the pathways we observe in S. Typhimurium infection in IECs.  
Instead, NK cells or CTLs can initiate caspase-7 activation by delivering granzyme B to infected 
targets. Therefore, there may be many pathways leading to caspase-7, and in some cells multiple 
paths may be open, while other cells may be more constrained.  Similarly, another source of 
caspase-7 activation may be IELs, which are themselves cytotoxic and may use their non-
classical MHC receptors and NK activating receptors to initiate cell death downstream of 
unknown, infection-related stimuli (7, 8). In our S. Typhimurium infection model these pathways 
are not at play since perforin knockout mice did not show defects (Fig. 3.3a).  However, it is 
likely that in models where perforin cytotoxicity was active against infected IECs that caspase-7 
would activate and cause exfoliation. 
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A final question is why caspase-7 does not protect mice from systemic infection from the 
gut by S. Typhimurium; that is, why do Casp7–/– mice not display higher burdens than WT, while 
displaying increased intestinal pathology? One explanation is that Salmonella has simply 
evolved around this defense, such that exfoliation is not a significant barrier to a bacterium that 
can rely on surveying myeloid cells and M cells to facilitate uptake – such that even non-motile 
bacteria lead to systemic infection (50). Another possibility is that our model may not provide 
resolution of the effect of caspase-7. For example, oral infection of C57BL/6 mice with S. 
Typhimurium requires pretreatment with streptomycin (51); otherwise, the bacteria cannot 
outcompete the microbiota and do not colonize the intestine. However, pre-treatment suppresses 
90% of the microbiota, leading to such an expansive outgrowth of S. Typhimurium in the lumen 
that the ability to colonize an adherent epithelial niche may be undetectable. It would thus be 
interesting to test a caspase inhibitor in a bovine ileal ligation loop model to determine if loss of 
caspase-7 function lead to increased epithelial-adherent bacteria, as has been previously tested 
with the tetrathionate respiration-deficient genes (e.g. ttrA) (52).  
While these data do not clarify these latter questions, what is clear is that caspase-7 has evolved 
as a unique, and physiologically important driver of epithelial extrusion. These data thus provide 
a heretofore unappreciated role for caspase-7, a previously poorly understood apoptotic 
executioner caspase. Our results may stimulate further research into this enigmatic protease.  
 
73 
MATERIALS AND METHODS 
 
Bioinformatics 
Data were extracted either from BioGPS (53), or analyzed via the built-in browser for 
Geo-datasets. Data for C57BL/6 mice were collected on the Affymetrix Mouse Genome 430 2.0 
Array (18). Data for BALB/c mice were collected on the Illumina MouseWG-6 v2.0 expression 
beadchip (16). Probes from each array were compared to their BLAT location on UCSC’s 
genome browser, and probes were discarded if they were in introns, had multiple hits, or were in 
the wrong gene.  
 
Mice 
Wild type C57BL/6 (Jackson), Rag1–/– (Jackson), Casp7–/– (Jackson), Casp1–/– Casp11–/– 
(54), Prf1–/–(Jackson), GsdmD–/– (2), Nlrc4–/– (55), and Nlrc4–/– Asc–/– (56) mice were used in this 
study. Where noted, heterozygous littermate controls were generated by crossing the strain to 
WT, then crossing knockouts to heterozygotes. All mice were 8-12 weeks old, male or female, 
and housed under SPF conditions. All protocols were approved by the Institutional Animal Care 
and Use Committee at the University of North Carolina at Chapel Hill, and met NIH guidelines 
for treatment and care of animals. 
  
DSS Treatments 
 SPF C57Bl/6 Casp7 –/– and Casp7 +/– littermate controls were fed 2.5% w/v DSS (TdB 
Consultancy) for 7 days. Animals were then either harvested for H&E staining, or given water to 




In vivo Infections 
 Mice were deprived of food and water for 4h prior to gavage with 20mg streptomycin, 
after which food and water were restored. Mice were infected with S. Typhimurium strain 
SL1344 unless indicated. Bacteria containing either pBR322 with either eGFP or mCherry under 
the promoter of rpsM was grown overnight to an OD between 2-6, then back-diluted for 2.5 
hours to late log phases. Bacteria were then diluted in PBS to 1-5*106 CFU/100ul. After 4 hours 
without food and water, mice were gavaged with 100ul of this inoculum, followed by 
reintroduction of water. After 2 hours, food was restored. Feces were collected daily and plated 
on LB plates containing appropriate antibiotics. Cecal tissues were pre-treated with 10ug/ml 
gentamicin for 1 hour at RT for intracellular cecal burdens. IFNγ was measured by DuoSet 
ELISA of serum (R&D Systems, DY485). Serum samples were separated (BD Microtainer Gold, 
385967)), and measured at 1:10 dilution according to the kit instructions.  
 
H&E Histology 
Cecal tissues were placed in 10% formalin for at least 48 hours prior to embedding, 
cutting, and H&E staining by the Cell Services and Histology Core. Slides were then given to a 
blinded scorer for assessment. For salmonella typhimurium infection: Histology was assessed 
using a modified scheme adapted from Barthel et al (57). Slides were blind scored using a 4-
point scale of severity for each of four criteria: epithelial hyperplasia and damage; immune 
infiltrate into the mucosa and lamina propria; goblet cell loss; and submucosal edema. For DSS, 






 Tissues for immunofluorescence were harvested from animals, placed in 4% PFA and 
incubated for 48 hours in the dark at room temperature. Tissues were then removed and placed in 
40% sucrose for at least 24 hours. Afterwards, samples were placed in optimal cutting 
temperature (OCT) compound and allowed to equilibrate for 3-4 hours. Tissues were then 
removed from OCT, placed in new OCT, and snap-frozen in cryomolds.  
 OCT blocks were either cut by the UNC Animal Histopathology & Lab Medicine Core, 
or cut by the investigators. For the latter, approximately 5um sections were cut non-serially from 
blocks and allowed to air dry prior to freezing at -80C for storage, or immediate staining.  
 Slides for staining were treated with -20C acetone for 20 minutes, followed by 30 
minutes of air-dry in the dark at RT. Tissues were then rehydrated in PBS for 1 hour, followed 
by 1% BSA in PBS for 1 hour. Primary antibodies were incubated overnight on the slides. 
Secondary antibodies and fluorophore-labelled phalloidin (ThermoFisher, Alexa Fluor-
conjugates) were incubated for 2 hours. After the final 1% BSA washes, slides were treated with 
DAPI-containing mount-media (Abcam, ab104139), and a coverslip was sealed on. Slides were 
imaged either the same day or the next day on an Olympus IX81 inverted microscope or on an 
Olympus FV1200 SP5 confocal microscope, and analyzed by ImageJ.  
 
Antibodies for IF and Western Blots 
 Primary antibodies used: Rabbit anti-cleaved caspase-3 (CST, D175); Rabbit anti-cleaved 
caspase-7 (CST, D198); Rabbit anti-cleaved caspase-8 (CST, 18C8); Rabbit anti-gelsolin (CST, 
D9W8Y); Mouse anti-βactin-HRP (abcam, ab8224); Rat anti-EpCAM (BioLegend, G8.8)  
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 Secondary antibodies used: Goat anti-rabbit HRP (CST, #7074); Goat anti-rabbit HRP 
(abcam, ab6721); Goat anti-rabbit IgG AlexaFluor 647 (abcam, ab150079); Goat anti-rabbit IgG 
AlexaFluor 555 (ThermoFisher, A-21428); Anti-rabbit IgG F(ab’)2 AlexaFluor 488 (CST, 4412); 
Donkey anti-rat IgG Alexa Fluor 488 (Jackson ImmunoResearch, 712-545-153).  
 
In vitro and ex vivo experiments 
 WT Bone marrow-derived macrophages (BMMs) were pre-treated with either media or 
50ng/ml E. coli LPS (where noted), then treated with 3μg/ml FlaTox or PrgJ-Tox, or infected 
with S. Typhimurium strain SL1344 unless otherwise indicated. Cell lysis was determined by 
measuring LDH release (60). Supernatants were removed at indicated times and remaining cells 
or PITs (61) were solubilized in 1x sample buffer for running on SDS-PAGE gels and Western 
Blots. Ex vivo small intestines were removed from animals immediately after death and placed 
on ice. All samples were filled with FlaTox or PBS and clamped at either end. Samples were 





Figure 3.1 Models of caspase-family interactions. (A) A non-exhaustive summary of the 
apoptotic and inflammatory caspases. (B) A working model of caspase-7 activation and 









Figure 3.2. Caspase-7 plays a critical role in intestinal biology and defense. (A) Caspase-7 
and -3 expression data was extracted from BioGPS(17). C57BL/6 data was extracted from (18); 
BALB/c data was extracted from (16). (B) Mice were treated with water or DSS as shown. (C) 
Histology was collected from mice harvested at day 9 and cecal and colonic tissue was scored 
and summed. (D) Representative histologic images displaying loss of epithelium and ulceration 
in Casp7–/– mice relative to WT. Representative images of mice infected with WT S. 
Typhimurium (E), bacteria expressing GFP (F,G)  or bacteria expressing mCherry pseudocolored 
green (H). (E) 40x image showing exfoliated cell; indicated insert from same image or separate. 
(F) 10x image of sloughing infected cells. (G) Representative 20x (upper left) or 40x (all others) 
images of microcolonies. Full arrows indicate bacterial microcolonies; open arrow indicates 
single bacterial adhesion. (H) Merged and split 40x images Upper left image is 20x; all others 
are 40x. All images taken on FV1200 confocal microscope. * is p<0.05 determined by ANOVA 




Figure 3.3. Perforin and Caspsae-3 are not required for caspase-7 activation after S. 
Typhimurium infection. Representative 10x images showing microcolonies 24 hours after 
infection (arrows, A), or sloughed cells 48 hours after infection (B). (C-D) Counted number of + 
cells; each dot represents a single mouse, for which 60 fields were counted. (E) Pathology 
scoring of cecal tissues only. IFNγ determined by ELISA of sera. CFUs enumerated by plating 
on antibiotic media. (F) Pathology and counting as before. * is p<0.05 by Student’s t test. Images 







Figure 3.4. Caspase-1 activation is required for rapid caspase-7 cleavage, exfoliation, and 
microcolony defense. Macrophages were infected with MOI 10 of late log-phase (SPI-1 
induced) bacteria (A) or treated with 3ug/ml PrgJ-Tox +/- 10mM glycine (B) for indicated times. 
Media was removed and frozen prior to LDH assay; cells were directly lysed in 25ul 1x sample 
buffer of which 10 (A) or 12 (B) was run. LDH is determined by normalizing to media and lysis 
wells; where no lysis wells were used, Abs 492nm is shown; ~0.9 is total lysis. (C) Small 
intestines were extracted from mice, fileted open, washed in PBS and placed in PBS on ice until 
placed in a dish with 3ug/ml PrgJ-Tox. Tissues were cut starting from the terminal ileum and 
placed in 4% PFA at each time point. Images are 10x taken on a BX61 widefield microscope. 
(D-E) Representative images 24 hours post infection; arrows indicate microcolonies. WT-
infected Casp7–/– omitted due to experimenter error. Data are representative of 1 (A, B, C) or 2 




Figure 3.5. Caspase-7 is not required for caspase-1- or caspase-11-mediated systemic 
defense.  (A) Macrophages were infected with indicated MOIs of either WT or SPI-1 deficient S. 
Typhimurium strain 14028s. (B) Mice were i.p.  infected for 2 days with S. Typhimurium CS401 
flgB or an isogenic strain constitutively expressing FliC (FliCON). Competitive index calculated 
from splenic CFUs (C). (D) Macrophages were treated with cholera toxin B, LPS, or both to 
deliver LPS to the cytosol. (E) i.p. Infection of mice with B. thailandensis for survival or 3 days. 












Figure 3.6. Absence of caspase-1 delays exfoliation due to delayed cleavage of gelsolin. 
Representative 10x images showing microcolonies 24 hours after infection (arrows, A), or 
sloughed cells 48 hours after infection (B). (C) Small intestines were extracted from mice, fileted 
open, washed in PBS and placed in PBS on ice until placed in a dish with 3ug/ml PrgJ-Tox. 
Tissues were cut starting from the terminal ileum and placed in 4% PFA at each time point. 
Macrophages were infected with MOI 10 of late log-phase (SPI-1 induced) bacteria (D) or 
treated with 3ug/ml PrgJ-Tox (E) for indicated times. All images taken on BX61 widefield 
microscope. Data in (A) are from the same experiment as Fig. 2a. Data in (B) are from the same 
experiment as Fig. 2b. Data in (C) are from the same experiment as Fig. 3c. Data in (D-E) are 
from the same experiments as Fig. 3a, b, respectively. Data are representative of 1 (C,D,E), 2 (B) 
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CHAPTER 4: DISCUSSION 
SUMMARY 
The gastrointestinal tract is a highly complicated organ susceptible to a number of 
infections and diseases. We are beginning to realize that to defend itself, the gut has adapted not 
only the universal immune defenses, but has also taken advantage of and diversified specific 
immune defenses not found in other tissues. These bespoke immune functions provide greater 
flexibility in responding to immune threats, and help tailor those responses to the specific threat 
at hand amidst a sea of diverse, potentially inflammatory stimuli. We now add two to the 
previously extensive list of heterodox defenses: sensing of sodium as an amplifier of 
inflammation; and activation of caspase-7 by inflammasomes as an exfoliative response to 
infectious microbes. However, the defenses we described undoubtedly have immunologic 
consequences beyond the limited contexts in which we have presented them, perhaps 
representing the culmination of countless adaptations to diverse selective pressures across 
evolutionary time. As such, we expand on the implications of our work here, discussing: 1) 
mechanisms for salt-enhanced immune activity beyond the p38 MAPK pathway; and 2) why the 
evolutionary context behind caspase-7 may have prevented full understanding of its function. 
 
PART I – Sodium Sensing as a Heterodox Defense of the Intestine 
 
It is now clear that the innate immune system in the GI tract is able to detect a number of 
complex stimuli and drive differing immune responses, ranging from anti-inflammatory signals 
downstream of SCFAs to pro-inflammatory signals downstream of high fat and high sugar diets. 
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Our data now add the concept of dietary Na+ surveillance as an input in inflammatory processes 
in the intestine. We describe how a high salt diet is capable of exacerbating the intestinal 
inflammation of both an adaptive, genetic model of chronic colitis (Il10–/–) as well as an innate, 
pathogen-driven model of colitis. We demonstrate that this inflammation is characterized by 
heightened transcription of Th1 and Th17 axis cytokines, likely driven by altered sodium 
concentrations in the colon leading to altered MAP kinase signaling in many immune cells, 
including dendritic cells.  
 These results agree with previously published work suggesting that dietary salt, like 
many components of the Western diet, appears to have strong effects on the immune system that 
may drive autoimmune disease. Indeed, there are reports that dietary salt treatment of mice can 
exacerbate encephalitis by expanding pathogenic Th17 cells in the EAE model of multiple 
sclerosis (1, 2), increase antigen presentation and co-stimulation in EAE (3), decrease Treg 
function in vitro and reduce suppression after transfer into T-cell mediated colitis and a model of 
graft-versus-host disease (4), and reduced M2-polarized macrophage suppressor function (5). 
Supporting these studies of the effects of sodium on T cells and macrophages are several reports 
in humans where controlled increases in sodium intake led to: increased IL-17a production by T 
cells in vitro and in vivo (6); elevated levels of monocytes as well as increased serum IL-6, IL-
23, and lower serum IL-10 (7); and increased expression of Ccl5 and decreased expression of M2 
macrophage marker Arg1 (8). Interestingly, one study showed that supplementation of high salt 
media and diets with potassium could reverse some of these effects, particularly Il17a 
expression(6).  
 Despite the additional interest in dietary salt as a driver of inflammation and 
autoimmunity, the mechanisms by which salt exercises such effects remains unclear. Studies 
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have focused on a p38→NFAT5→SGK1 axis that enhances inflammatory cytokine production 
in T cells, macrophages, and DCs{Schatz:2016bm}. In addition, a similar axis may also exist in 
ILCs and epithelial cells which has not yet been investigated.  Nevertheless, how dietary salt 
activates p38 has not been elucidated. It is known that a hyperosmolar environment can activate 
p38 MAPK as well as other signaling cascades (such as ERK1/2), leading to Regulatory Volume 
Increase (9). Previous data, however, seems to suggest that p38 activation is independent of 
osmolarity, as treatment of macrophages with mannitol in place of sodium did not elicit the same 
loss of M2-polarized suppressor function (5). Another possibility is that sodium does not directly 
activate p38, but may prevent dephosphorylation via downregulation of dual-specificity 
phosphatases (DUSPs). Indeed, our own data suggest that p38 phosphorylation in bone marrow-
derived macrophages may not be stronger at certain time points, but may last longer in high salt 
conditions. However, our own brief examination of DUSP1, the most well characterized DUSP, 
suggested it was uninvolved (data not shown). Finally, mineralocorticoid regulatory hormones 
secreted by the kidney such as aldosterone are strongly impacted by dietary salt, and may have 
immune functions similar to glucocorticoids (10). Thus, inflammatory states may be controlled 
by hormones derived from distal sites. Future work examining the molecular mechanism by 
which sodium can drive pro-inflammatory cytokine production may yield useful new therapeutic 
targets to inhibit dietary-driven inflammation.  
 Similarly, the mechanisms for sodium-dependent inflammation downstream of SGK1 are 
also unclear. Numerous mechanisms have now been published suggesting dietary salt has effects 
on macrophages, T cells, and DCs, which may all combine to drive inflammation. Nevertheless, 
how these cells can drive inflammation in sites distal to the increased sodium concentrations of 
the skin (11) or intestine (12) has yet to be elucidated. Perhaps sentinel cells at these sites 
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integrate sodium concentrations and drive increased systemic cytokine production, which can 
then enhance the inflammatory activity of T cells at distal tissues. Alternatively, perhaps the 
enhanced cytokine production and SGK1 activation in the intestine leads to an over-expansion of 
T cells in the gut which can then traffic to the brain and causes disease during EAE, as 
previously proposed (1). If this is the case, enhanced cytokine secretion by DCs in the intestine 
may augment the direct effect of salt on T cells in the lymphoid tissue of the intestine.  
 Of course, direct effects mediated by p38 and SGK1 may not be the only effect of a HSD 
in vivo, and many mechanisms may work in parallel. One obvious option would be that dietary 
salt could alter the microbiota, as has already been demonstrated in fish (13). A pathogenic 
outcome from such microbiota manipulation would not be surprising, given that many 
immunologically important bacteria expand or contract under certain dietary conditions. For 
example, carbohydrate-rich diets can result in the outgrowth of Prevotella spp. (14)(15). 
Likewise, Bacteroidetes spp. also adapt to dietary factors, typically expanding under high 
protein, low fiber diets (15). Further, changes to these microbial populations can have significant 
knock-on effects that may drive further compositional or functional changes. For example, 
Prevotella are thought to degrade mucin (16), and this function is thought to be enhanced by the 
presence of species like Desulfovibrio which consume sulphates and thus enhance mucin 
desulphation (a precursor to degradation) (17). Indeed, very recently published data shows that 
dietary salt can lead to the depletion of a probiotic Lactobacillus in mice and humans, resulting 
in aggravated Th17 populations that drive EAE and Th17-driven atherosclerosis (18). In 
addition, dietary factors like salt could drive host responses that also affect microbiota 
composition, as in the case of milk fats, which promote taurine-conjugation of bile acids that in 
turn increase populations of Bilophilia wadsworthia, culminating in colitis (19). Similarly, salt 
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could alter bacterial function, if not population size, as has already been demonstrated with the 
strong effect of sodium on the cag gene island of Helicobacter pylori (20). Any or all of these 
mechanisms layered on another may result in significant pro-inflammatory signals and thus drive 
autoimmunity.  
Leaving aside indirect mechanisms of dietary salt-mediated inflammation exacerbation, 
one may speculate why the immune system would be designed to directly respond to dietary salt 
as a pro-inflammatory signal. The use of ubiquitous and widely expressed molecules to convert 
hypersalinity into cytokines suggests the mechanism is evolutionarily ancient. It is possible that 
such a system evolved as a way to direct increased inflammation at barrier surfaces. Thus, where 
breach has occurred, external sodium alerts the immune system to a breach, enhancing wound 
closure as has been shown in zebrafish (21). Similarly, breaches at barriers may signify potential 
infection, and thus warrant more severe inflammation. Such seems to be the case in the skin, 
where sodium-exacerbated inflammation helped to clear Leishmania major infection (11). 
Whatever the mechanism, our ability to sense and respond to sodium concentrations has clear 




PART II – Heterodox Intestinal Defense by Caspase-7-Mediated Exfoliation  
 
 Inflammasomes are critical defenses against intracellular pathogens, initiating release of 
two potent cytokines and eliminating the replicative niche via programmed cell death (22). 
However, many pathogens have evolved mechanisms to escape inflammasome detection in order 
to successfully infect. This is illustrated by the relatively modest protection afforded by 
inflammasome-sufficient mice compared to knockout mice in a number of models, and by the 
potent, sterilizing protection afforded against opportunists that do not avoid inflammasome 
activation (23). Of the professional pathogens that are weakly defended by inflammasomes, S. 
Typhimurium is perhaps the prototypical example, the original work describing pyroptosis 
having been performed using SPI-1 induced bacterial infections (24). Subsequent work 
demonstrated the utility of inflammasomes against S. Typhimurium during systemic infection, or 
by focusing on the innate immune cells the bacteria infects.  
 More recently, there has been a greater appreciation for the fact that inflammasomes 
defend more than just the hematopoetic compartment. For example, several reports indicate that 
inflammasomes are also active and functionally important defenders of the intestinal epithelial 
niche. Specifically, loss of IEC inflammasomes enhanced S. Typhimurium’s ability to infect the 
cecal tissue (25, 26). Interestingly, this report also separated the roles of inflammasomes from 
their downstream caspase-1 activation and pyroptosis, as Nlrc4–/– mice harbored greater burdens 
than did Casp1–/– mice. This result lead to the discovery that defense of the cecal epithelium by 
inflammasomes included not merely cytokine release (which, in the case of S. Typhimurium, can 
be pathologic (27)), or pyroptosis of the cell, but also due to exfoliation of the cell.  
Previous reports had indicated that S. Typhimurium infection in the intestine drove 
exfoliation of the infected IEC, and that this was dependent on NLRC4 detection of SPI-1 
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components (25, 28). The novelty in these data, however, surrounded the concept of 
inflammasomes initiating apoptotic exfoliative processes, presumably by caspase-8-mediated 
caspase-3 cleavage. Thus, the inflammatory and apoptotic caspases were linked in the epithelial 
cell.  
Our data now show that the primary mediator of exfoliation downstream of 
inflammasomes is not caspase-3, as was previously thought, but caspase-7. This was surprising, 
as previously all apoptotic processes were thought to be accomplished by caspase-3 alone, and 
caspase-7 seemed to serve as an inefficient backup with cryptic functions (29-32). Instead, we 
demonstrate that caspase-7 cleavage downstream of caspase-1 – and presumably also caspase-8 
at later time points – can exfoliate infected cells. This could occur by caspase-7 cleaving the 
actin-severing protein gelsolin, by cleaving focal adhesion kinase, or by cleaving other as yet 
unknown substrates. Regardless of the targets, our data shows that caspase-3 is unable to drive 
exfoliation by itself in the absence of caspase-7. Thus, caspase-7 is a unique apoptotic caspase 
adapted to rapid dismantling of the cytoskeleton upon inflammasome-dependent activation.  
  Indeed, this may in part explain why the function of caspase-7 remained unexplained for 
so long. As noted above, because many of the pathogens which might otherwise have been used 
to study caspase-7 effectively evade inflammasomes and thus generate weak phenotypes, the 
presence or absence of caspase-7 may have had little effect on these models. Similarly, because 
most work studying inflammasomes is done at the systemic level, or on macrophages in a dish, 
the role of cytoskeletal dismantling may have been diminished. For example, caspase-7 was 
shown to mediate detachment following serum starvation in tissue culture of MEFs (33). 
Similarly, transfection of active gelsolin alone can cause cells to round and detach from dishes, 
(34). However, these phenotypes may have been overlooked because dismantling of the 
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cytoskeleton of macrophages in vitro or splenocytes in vivo may have very little effect on 
pyroptosis or bacterial burdens. In consequence, one of the first major discoveries of the 
importance of caspase-7 in vivo was made during infection of hepatocytes (a structurally 
complicated cell with an extensive cytoskeleton) by Chromobacterium violaceum, a bacterium 
that does not evade inflammasomes (Maltez, Mitchell, Tubbs et al, manuscript in submission).  
Similarly, this may explain why, although caspase-7 activation leads to exfoliation of 
cells during S. Typhimurium infection, the presence or absence of this defense does not appear to 
impact bacterial burdens in vivo. Salmonella can effectively evade caspase-1 activation by 
switching to a non-detectable SPI-2 system once in an epithelial cell (28), and is also rapidly 
taken up by M cells, sampling monocytes, and Peyer’s patches. Thus, expulsion of epithelial 
cells may not remove a large enough portion of the epithelial population to be detectable. 
Instead, the most affected population appears to be an adherent population that is not countable 
in traditional, gentamicin-protection assays of cecal bacterial burden. Indeed, this population 
may be the driver behind the exacerbated inflammation and IL-18 secretion observed 48 hours 
post infection (Fig. 3.3e). Further, while macrophages also express caspase-7 and rapidly cleave 
it upon caspase-1 activation (Fig. 3.4b), the need for removal of focal adhesions may be minimal 
in a cell type that will pyroptose in situ.  
While the highly inflammatory pyroptotic cell death pathways and the immunologically-
silent apoptotic cell death pathways are distinct in most tissues, it is still curious that some cell 
types would use express caspase-7 in order to bridge these pathways. This is particularly 
interesting given that while pyroptosis is capable of rapidly clearing S. Typhimurium in vivo, 
new data suggest that apoptosis of infected cells may actually hinder clearance of bacterial 
burdens in mice (T. Abele and E. Miao, unpublished data). Thus, there seems to be some risk to 
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linking apoptosis and pyroptosis. This again may also explain the role of caspase-7, since 
caspase-7 may be capable of executing only the effector mechanisms necessary for exfoliation 
without activating the full apoptotic program that could be deleterious. Similarly, the fact that 
caspase-8-dependent cleavage of caspases-3 and -7 only seems to occur when caspase-1 is absent 
implies that exfoliation, even with inappropriate activation of apoptotic caspases, is more 
advantageous than no exfoliation at all. Thus, the ASC→caspase-8 pathway may serve as an 
anti-pathogenic backup in case of caspase-1-inhibition – this is supported by the fact that Casp1–
/–Casp11–/– mice harbor cecal burdens in between those of WT and Nlrc4–/– mice (26).  
Nevertheless, if exfoliation is such a critical pathway that it is initiated downstream of 
both the primary inflammasome output in IECs, as well as the apoptotic backup, then why does it 
not seem particularly effective a defense against intestinal pathogens? Again, our experiences 
with systemic infection by Chromobacterium violaceum may provide some illumination here. As 
noted above, S. Typhimurium may have co-evolved with caspase-7 activity in multicellular 
organisms, such that it can either evade or use activation to its advantage. The same may be true 
of extracellular, mouse-adapted adherent pathogens such as Citrobacter rodentium and adherent-
invasive E. coli strains. However, there may be unknown intestinal pathogens that are robustly 
defeated by this exfoliative strategy and have not been identified because they do not regularly 
infect mice or humans. Alternatively, some pathogens which have highly evolved mechanisms to 
inhibit and disrupt apoptosis in humans may be uniquely susceptible to this defense in mice. For 
example, enteropathogenic E. coli have a number of effectors capable of interfering with caspase 
activation and apoptosis – presumably to enable them to inhabit the adherent niche – and yet 
cannot colonize mice (35, 36). It would be fascinating to discover whether EPEC or a human-
adapted adherent-invasive E. coli (such as strain LF82) could uniquely infect Casp7–/– mice.  
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In conclusion, our data illustrate a novel defensive mechanism downstream of inflammasomes 
that leads to exfoliation of epithelial cells in vivo. This mechanism, mediated by the previously 
poorly characterized caspase-7, opens the door to new investigations of caspase-7 in multiple cell 
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